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1
1 Introduction 
 
 
1.1 Chirality1,2 
 
The phenomenon of chirality is easy to see for everyone of us just by looking at our 
hands. Left and right hand behave like image and mirror image (Figure 1), but they 
cannot be superimposed on each other. In 1884 LORD KELVIN introduced the term 
chirality for this characteristic feature. He deduced it from the Greek word “χειρ” = 
cheir, which means nothing else as hand. However, it was PASTEUR who was the first 
to discover chirality in chemistry. In his famous experiment in 1848, he observed two 
different forms of hemihedral crystals when crystallizing an aqueous solution of sodium 
ammonium tartrate. By manual resolution just with a hand lens and a pair of tweezers, 
he separated two different forms of crystals which showed opposite optical rotations in 
solution.  
 
 
 
 
 
Figure 1: Chirality of hands3 and NaNH4 tartrate crystals2 
 
But PASTEUR could not explain what made the difference of the molecular structure of 
these two kinds of crystals. In 1874, 26 years later, VAN´T HOFF and LE BEL found an 
explanation for the phenomenon of chirality, reduced to the structural configuration of 
chemical molecules. Independent from each other, they proposed that the four valencies 
of a carbon atom are directed towards the corners of a regular tetrahedron. With four 
different substituents, just two different tetrahedra can be obtained (Figure 2).  
 
 
 
 
 
 
Figure 2: Asymmetrically substituted carbon atoms enantiomeric to each other 
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The two tetrahedra are chiral. They contain no element of symmetry. They are 
enantiomers. Chirality concerns all life on earth. Many natural compounds only exist as 
single enantiomers, for example L-amino acids and D-sugars. This phenomenon is called 
biological homochirality. To date, there are many theories how this homochirality may 
have developed2,4,5. Chiral induction by polarized light or crystallization was proposed 
for the genesis of biological homochirality on earth. Until today, there is no final theory 
for this phenomenon.  
 
 
1.2 Chiral switch6,7 
 
The consequences of biological homochirality are extensive. As the receptors of our 
body are also chiral, the different enantiomers of pharmaceuticals have a different effect 
on us. The enantiomer with the desired pharmaceutical effect is called eutomer, the one 
with no or undesired effects is called distomer. In the case of Naproxen®, an anti-
inflammatory agent, the (S)-enantiomer is 28 times more active than the (R)-enantiomer8 
(Figure 3). Therefore, the (R)-enantiomer can be seen as isomeric ballast which has to 
metabolized by the body. Another interesting example is the agent Propanolol®.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Different pharmaceutical properties of enantiomers 
 
While the (R)-enantiomer is a ß-blocker and taken in case of hypertension, the (S)-form 
has a completely different effect – it is a contraceptive. These two examples show the 
pressure towards enantiopure drugs. In 1992 the American Food and Drug 
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Administration (FDA) complicated the approval of racemic drugs. Other countries 
followed. Therefore, pharmaceutical companies are urged to develop enantiopure drugs. 
The development of single enantiomer drugs in place of the previous racemic mixture is 
called “chiral switch”. Enantiopure pharmaceuticals are also desirable for the producers 
due to economic aspects. If a drug was patented as a racemate, it is possible to get a new 
patent for the single enantiomer. Some companies specialized on that niche, for example 
Sepracor. 
  
The local anaesthetic Bupivacaine®, which was sold as a racemate, made headlines in 
1979. Cases of sudden cardiovascular collapse with difficult resuscitation or death were 
reported. It turned out that the (S)-isomer was significantly less cardiotoxic than the 
antipode and the racemate. Therefore, Bupivacaine® was “switched” to 
Levobupivacaine® (Figure 4). An example for a current, successful chiral switch is the 
synthesis of Perprazole®, the (S)-form of Omeprazole®. It is a medicament for the 
treatment of reflux oesophagitis. The single enantiomer shows increased activitity.   
 
 
 
 
 
 
Figure 4: Three examples for chiral switches 
 
However, even with enantiopure drugs failures on the pharmaceutical market may 
happen. One rare example is the luckless introduction of the appetite suppressor 
Dexfenfluramine® in the market, the D-isomer of the formerly racemic drug 
Fenfluramine®. First the enantiopure agent showed increased potency and tolerance. 
Indeed, when in the market, the enantiopure drug caused stronger side effects than the 
racemic mixture. Due to a perceived risk of pulmonary hypertension, it was withdrawn 
from the market in 1997. 
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1.3 Enantioselective catalysis9,10 
 
There are different possibilities to obtain enantiopure substances. Separation methods 
like optical resolution or chromatography imply a waste of substrate and solvents. 
Furthermore, they are quite work-intensive. It is more efficient to start the synthesis with 
enantiopure substrates from the “chiral pool”, e.g. amino acids or sugars, or to access 
from the so called “new pool”, i. e. commercially available, unnatural chiral substances. 
But in these cases the synthesis is restricted in terms of suitable and available chiral 
substrates. Asymmetric synthesis is much more manifold. There are different 
possibilities for asymmetric synthesis: with enzymes, with chiral auxiliaries or with 
catalysts. Enzymes are powerful biocatalysts, but sensitive to certain chemicals and 
restricted to certain substances and reaction classes. Chiral auxiliaries have the 
disadvantage that they are needed in stoichiometric amounts.  
 
Asymmetric catalysis has some advantages compared to the methods mentioned above. 
Using a substoichiometric amount of a chiral catalyst, in the best case only the desired 
enantiomer is obtained and the catalyst can be recycled. Interestingly, many powerful 
catalysts in modern asymmetric catalysis are derived from the chiral pool. Let us return 
to PASTEUR´s tartaric acid − with only a slight derivatisation to the ethyl ester, it turned 
out to be a highly enantioselective cocatalyst in the SHARPLESS epoxydation11 (Figure 
5). The bidentate phosphane ligand DIOP of KAGAN was a breakthrough in the 
development of hydrogenation of olefins in 197112.  
 
 
 
 
 
 
 
 
Figure 5: Successful catalysts derived from tartaric acid  
 
The TADDOL type ligands from SEEBACH are powerful catalysts for many different 
reactions, e.g. DIELS-ALDER reactions, [2+2] cycloadditions and addition of Et2Zn or 
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Me3SiCN to aldehydes13. These three examples of catalysts show that the derivatisation 
of a quite simple basic structure from the chiral pool may lead to successful 
enantioselective catalysts in different chemical reactions.  
 
An asymmetric catalysis which is known for a long time but which gained interest no 
more than in the last two decades is the enantioselective decarboxylation. In this 
catalysis, alkaloids from the chiral pool were applied as catalysts and derivatives of them 
helped to increase the enantiomeric excess. The evolution of this catalysis is described in 
the next chapter.  
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2 General Part 
 
 
2.1 Enantioselective decarboxylation 
 
 
The first enantioselective decarboxylation reaction was carried out by MARCKWALD 
in 190414,15. He heated the brucine salt of ethylmethylmalonic acid and obtained 2-
methylbutyric acid with 10% ee (Figure 6).  
 
 
 
 
Figure 6: First enantioselective decarboxylation by MARCKWALD (1904) 
 
In the following decades, only few publications followed, all with disappointing 
results16,17. 1986 TOUSSAINT revitalized interest in enantioselective decarboxylation 
reactions, using copper(I) salts and cinchona alkaloids as catalysts (Figure 7)18,19. With 
2-alkyl-2-phenylmalonic acid derivatives as substrate he achieved up to 31% ee. He 
postulated a catalytic cycle based on Cu(I). While the isolation of new Cu(I) malonato 
 
 
 
 
Figure 7: Enantioselective decarboxylation using Cu(I) salts, TOUSSAINT  
 
complexes first confirmed the role of the metal as catalyst in the decarboxylation of 
malonic acids20, the importance of copper was questioned in following 
publications21,22,23. It turned out that the reaction was not Cu(I) catalyzed but base 
catalyzed22. Hence, decarboxylations with CuCl were considerably slower than with the 
much more basic Cu2O. Therefore, Cu(I) is not necessary as catalyst, the organic 
nitrogen base on its own is sufficient. Using only 10 mol% of cinchonine as chiral base 
and no copper(I) salt, the enantiomeric excess in the decarboxylation of ethyl 2-methyl-
2-phenylmalonate was increased to 35% ee (compare to Figure 7). Also using only 
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commercial cinchona alkaloids as catalysts, KIM got optically active β-
hydroxyisobutyric acid by enantioselective decarboxylation, but only with 18% ee24. 
Screening different modified cinchona alkaloid derivates as catalysts, SCHMIDT 
achieved clearly improved chiral induction. With substoichiometric amounts of those 
modified bases as catalyst, he obtained the Naproxen® derivative 2-(6-
methoxynaphtalene-2-yl)propionitrile with up to 72% ee (Figure 8)25,26. While natural 
cinchona alkaloids only induced up to 34% ee, it appeared that benzamide derivatives of 
9-amino(9-deoxy)epichinchonine were the most successful catalytically active bases in 
this system. 
 
 
 
 
 
 
Figure 8: Enantioselective decarboxylation leading to a Naproxen® derivative 
 
Parallel to these studies, HÉNIN and MUZART prepared optically active cyclic27,28,29 
ketones via palladium-induced cascade reactions, including the enantioselective 
decarboxylation step. They used benzyl ß-oxo esters as starting material, the ultimate 
decarboxylation reaction took place after the deprotection of the ß-oxo ester by 
hydrogenolysis. 
 
 
 
 
 
Figure 9: The Pd-induced cascade reaction arriving at 2-methyl-1-tetralone 
 
In their cyclic systems, simple ß-aminoalcohols like ephedrine gave better results than 
cinchona alkaloids. Aminoborneol turned out to be the best catalyst for the 2-methyl-1-
tetralone system (Figure 9). With indanone derivatives as substrate even 99.5% ee was 
achieved. 
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On the other hand, when they used linear30,31 starting materials to their cascade reaction, 
the situation changed. Unmodified cinchona alkaloids afforded promising enantiomeric 
excess up to 71% ee (Figure 10), while the ß-aminoalcohols which were effective for 
the cyclic system only gave low inductions up to 16% ee. 
 
 
 
 
 
Figure 10: Applying the Pd-induced cascade reaction to linear substrates 
 
In my diploma thesis, I applied the enantioselective decarboxylation in order to obtain 
α-amino acid derivatives32. Employing ethyl 2-N-acetylamino-2-methylmalonic acid as 
substrate, 19% ee were obtained with the ortho-ethoxy-substituted N-(9-
deoxyepicinchonine-9-yl)benzamide catalyst from the Naproxen® system (Figure 11). 
Commercial cinchona alkaloids were inferior. 
 
 
 
 
 
 
 
Figure 11: Arriving at α-amino acid derivative ethyl N-acetylalaninate 
 
In a recent publication, the group of LASNE reported on a similar system using a cyclic 
substrate (Figure 12)33. In this system, again a derivatised cinchona alkaloid gave the 
best results. 
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Figure 12: Arriving at α-amino acid derivative N-acetyl pipecolic acid ethyl ester 
 
Interestingly, in some cases a “simple” ß-aminoalcohol or an unmodified cinchona 
alkaloid may also lead to promising enantiomeric excess. Therefore, the origin of the 
enantiomeric excess in this type of catalysis and the role of the base will be discussed 
next. 
 
 
 
2.2 Protonation of enolic species 
 
 
How can the optical induction in enantioselective decarboxylation be explained? If a 
malonic acid derivative or ß-oxo acid is heated, CO2 separates34 (Figure 13). This 
happens via a six-membered ring transition state. The generated enol tautomerises and a 
racemic product is found. 
 
 
 
 
 
Figure 13: Thermal decarboxylation of a ß-oxo acid 
 
In the presence of a chiral base, e.g. cinchona alkaloids or ß-aminoalcohols, after 
abstraction of the acid proton by the base and decarboxylation, a mesomerically 
stabilized carbanion originates (Figure 14). The stability of this intermediate depends on 
the residues R1, R2 and R3. Substituents with –I and –M effects stabilize the negative 
charge and facilitate the decarboxylation step.  
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Figure 14: Mechanism of the base catalysed decarboxylation 
 
Besides the electronical properties of the substituents, their sterical demand also has to 
be taken into account. The planar enolate is a prochiral intermediate. With a chiral, 
protonated base [B-H]+, the si and re face protonation should take place at different 
rates. Therefore, the enantiomers should be obtained in different quantities (Figure 15). 
After this reprotonation step, the chiral base B is available for another catalytic cycle.  
 
 
 
 
 
 
 
 
 
 
Figure 15: Enantioselective protonation of the enolate 
 
Pioneering work in the enantioselective protonation of enolates was done by 
DUHAMEL35. His first “deracemication” of  α-amino acid derivatives using Li-salts of 
secondary amines as base and a tartaric acid derivative as proton source achieved 70% 
ee. The enantioselective protonation of enolates gained interest and the research on it 
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increased strongly36,37,38. Nevertheless, it is a complex reaction. The proton exchange 
reactions between the electronegative atoms are very fast, diffusion controlled reactions. 
Therefore, it is hard to distinguish between the different possible reactants and 
intermediates. They can transform rapidly into each other. Furthermore, solvation, 
aggregation and complexation effects  affect the kinetically controlled reaction.  
 
There are different possible routes for the formation of the product. The protonation of 
the enolate at the oxygen results in an enol. This enol could act as an undesired proton 
source for the C-protonation of the enolate. Depending on the reaction conditions, a 
partial thermal decarboxylation as described above is also possible. Furthermore, the 
enol can tautomerise enantioselectively in the prescense of a ß-aminoalcohol (Figure 
16). The protonation of the enol was proposed in the following way39: The hydrogen  
 
 
 
 
 
Figure 16: Enantioselective Tautomerisation (residues R1-3 left out) 
 
bonding between the enol proton and the N-atom increases the electron density at α-C 
and leads to a more or less concerted proton transfer via a cyclic, nine-membered ring 
transition state.  
 
Besides, there is a difference between the catalytic decarboxylation systems starting 
with a free acid as substrate and those starting from a benzyl protected one. In the case 
of an unprotected substrate, a catalytic amount (10 mol%) of the chiral base is used. In 
the protected system, also a substoichiometric amount (30 mol%) of base is applied. But 
in this case, the real substrate, namely the deprotected acid has to be formed first by the 
Pd-induced deprotection step. Therefore, there is an excess of base in the reaction 
mixture. Indeed, the deprotection step bears another possibility which leads to 
racemisation – the reductive elimination of a Pd-enolate. On the other hand, the Pd-
induced cascade reaction method allows to use starting materials which are not stable as 
free acid. 
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The structure of the substrate also has to be taken into account. With linear substrates, 
E/Z isomerism of the enol(ate) has to be considered, while the geometry of cyclic 
enol(ates) is fixed. But obviously the cyclic substrates are not superior to the linear 
ones, they just may prefer another catalyst. Concerning the different substituents of the 
enol(ate), R3 seems to have only a minor effect on the enantiomeric excess, while R1 
and R2 do influence the results30.  
 
As discussed in the previous chapter, alkaloids with a ß-aminoalcohol moiety turned out 
to be suitable catalysts for the decarboxylation/reprotonation step. In most cases, 
already unmodified, commercial cinchona alkaloids gave promising results. Moreover, 
derivatives of them improved the results. Therefore, the class of cinchona alkaloids 
should be considered more closely.  
 
2.3 Cinchona alkaloids as catalysts 
 
Cinchona alkaloids are natural products, extracted from the dried bark of the cinchona 
tree (Cinchona officinalis)40. The mainly isolated products are cinchonine, cinchonidine, 
quinine and quinidine (Figure 17).  
 
 
 
 
 
 
Figure 17: Commercially available cinchona alkaloids 
 
Their structure is based on a quinoline ring which is linked over a hydroxymethylene 
bridge with a vinylated quinuclidine system. Although cinchonine/cinchonidine and 
quinidine/quinine are diastereomers, due to the fixed geometry of the quinuclidine 
residue, they mostly behave like enantiomers. 
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Further derivatives which are found in the bark are the epibases with reversed 
configuration for the hydroxy group and the dihydro derivatives with an ethyl residue 
instead of a vinyl residue attached to the quinuclidine system. The dihydro derivatives 
are difficult to separate from the vinyl bases. Therefore, commercial cinchona alkaloids 
contain 5 to 10 percent of the dihydro derivatives. 
 
The numbering of the framework was recommended by RABE, who did pioneering 
work in the structure determination of this substance class41. From their structure, the 
cinchona alkaloids can be considered as ß-aminoalcohols, concerning their hydroxy 
function and the nitrogen of the quinuclidine system.  
 
 
 
 
 
 
 
 
 
Figure 18: Derivatisation sites for different catalytic purposes 
 
With their quinuclidine nitrogen, the vinyl system and the hydroxy group, they have 
derivatisation sites for different purposes (Figure 18). Cinchona alkaloids and their 
derivatives are versatile catalysts in modern asymmetric catalysis42. Quaternary salts are 
used for asymmetric phase transfer reactions, for example for α-alkylations of carbonyl 
compounds43, Michael additions44 and epoxidation of enones45,46. All three 
derivatisation sites (quinuclidine N rather rarely) can also be used to attach the molecule 
to a solid support which enables heterogeneous catalysis. The most common type is the 
one with the polymer attached to the vinyl group. This heterogeneous catalyst type 
worked well e.g. for the SHARPLESS asymmetric dihydroxylation (AD) 47. The 
hydroxy function at the C9 position allows manifold derivatisations. Ether derivatives 
for example turned out to be very efficient catalysts in the SHARPLESS asymmetric 
dihydroxylation (AD)48 and asymmetric aminohydroxylation (AA) 49.  
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The replacement of the hydroxy group by an amino group under inversion of 
configuration afforded 9-amino(9-deoxy)epicinchona alkaloid derivatives which enable 
the formation of amide, imine and amine derivatives50,51. These modified epicinchona 
alkaloids were applied to different asymmetric catalysis systems: in the addition of 
diethylzinc to benzaldehyde they gave promising results with almost 80% ee. In 
asymmetric dihydroxylation of styrene, the hydrogenation of methylpyruvate and the  
hydrosilylation of acetophenone they were less successful51. It appeared that the 
benzamide derivatives of 9-amino(9-deoxy)epicinchona alkaloids were appropriate 
catalysts for the enantioselective decarboxylation25,26.  
 
In the case of enantioselective decarboxylation, the catalyst acts as a base, inducing 
chirality in the protonation step of the enolic species. With a basicity 103 times higher 
compared to that of the quinoline nitrogen, it is the quinuclidine nitrogen which will 
take the protonation part. This was confirmed by SCHMIDT, as the benzamide 
derivative of 9-amino(9-deoxy)epicinchonine with the N-oxide protected quinoline 
nitrogen gave similar inductions like the unprotected one25. With their rigid 
quinuclidine framework, they are sterical demanding bases in contrast to “simple” ß-
aminoalcohols. Furthermore, the different possible conformations due to rotation around 
the C8-C9 and C4´-C9 bond have to be considered. Conformation analysis was 
performed and it turned out that the protonated benzamide derivatives prefer an open 
conformation in solution as well as in the solid state, which means that the quinuclidine 
nitrogen points away from the quinuclidine ring52. Based upon that knowledge, a 
computational study was published to explain the enantiodiscriminating step in the 
Naproxen® system53. However, this semiempirical calculation led to wrong conclusions 
(see chapter 4.2.2.4).  
 
Due to the complexity of the protonation of the enol(ate) intermediate, the optimum 
catalytically active base cannot be “predicted” by rational design. Obviously, the 
different catalytic systems known to literature need different chiral inductors for 
improved enantiomeric excess. Therefore, empirical testing of several derivatives for 
each new catalytic system is necessary.  
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3 Synthesis 
 
3.1 Goals of this study 
 
In the work at hand, the application of the enantioselective decarboxylation in order to 
arrive at enantioenriched α-amino acid derivatives, was extended (Figure 19). New 
substrates were employed and further cinchona alkaloid derivatives were tested as 
catalytically active bases.  
 
 
 
 
 
 
Figure 19: Enantioselective decarboxylation leading to α-amino acid derivatives 
 
Furthermore, within the scope of a Marie Curie fellowship at the university of Reims, 
the Pd induced cascade reaction developed in the group of HÉNIN and MUZART was 
employed in order to obtain enantioenriched α-fluoro ketones (Figure 20).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20: Enantioselective decarboxylation arriving at α-fluoro ketones 
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3.2 Synthesis of substrates for the enantioselective  
      decarboxylation 
 
 
 
As most of the synthesised compounds are known to literature or were made analogous 
to it, this chapter will only give a short overview on the different reactions. The precise 
description is presented in the experimental part (chapter 5).  
 
 
3.2.1 Synthesis of 2-N-acetylamino-2-alkylmalonic acid monoethyl  
          esters  
 
The substrates for the catalysis leading to α-amino acid derivatives, 2-N-acetylamino-2-
alkylmalonic acid monoethyl esters, were prepared in two steps, starting from precursor 
13 (Figure 21). Diethyl 2-N-acetylaminomalonate 13 is also important in industrial 
amino acid synthesis54.  
In the first step, malonate derivative 13 was alkylated using NaOEt as a base and then 
refluxed with the appropriate alkyl halide (Figure 21). Synthesis and work-up of 1455, 
1556, 1657 was done according to the literature. 
Figure 21: Alkylation of precursor diethyl 2-N-acetylaminomalonate 13 
 
In the second step, the alkylated malonates 14, 15 and 16 were partially saponified with 
KOH in aqueous ethanol at room temp. to obtain hemiesters 158, 2 and 359. 
 
Furthermore it was attempted to obtain 2-N-acetylamino-2-ethoxycarbonyl-2-
phenylacetic acid. But the saponification of the corresponding diethylester always 
arrived at the decarboxylation product ethyl N-acetylphenylglycinate. Therefore, it 
seems that the free acid is not stable.   
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3.2.2 Synthesis of α-fluorinated β-keto esters 
 
3.2.2.1 Synthesis of benzyl β-keto esters 
 
For the catalysis leading to α-fluoro ketones, benzyl ß-keto esters were synthesised 
which were then fluorinated.  
 
The linear β-ketoester 3-oxo-2,3-diphenyl-propionic acid benzyl ester 1930 was prepared 
in two steps (Figure 22). In the first step, ester 1830 was formed from phenylacetic acid 
17 by reaction with benzyl bromide. The benzoylation of this ester was done using the 
base BuLi/hexamethyldisilazane (HMDS).  
 
 
 
 
 
Figure 22: Synthesis of the linear benzyl ester 19 
 
The cyclic ethyl β-keto esters 2160 and 2423 were prepared by Claisen condensation, 
starting from cyclohexanone 20 and 1-tetralone 23 which were treated with NaH and a 
large excess of diethyl carbonate (Figure 23). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: Preparation of the cyclic benzyl ß-keto esters 22 and 25  
 
To obtain the desired benzyl esters 22 and 25, the ethyl esters 21 and 24 were 
transesterified (Figure 23) analogous to literature procedures61. The reaction was carried 
out without acid or base, just refluxing the ß-keto ester with an excess of benzyl alcohol 
in toluene.  
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3.2.2.2 Fluorination of β-keto esters 
 
The first reagents used for electrophilic fluorination of carbanions were 
perchlorylfluoride FClO3, xenon difluoride, XeF2 and hypofluorites62. But these 
fluorination reagents have some disadvantages: only moderate selectivity, quite 
expensive and dangerous to use as they are powerful oxidants for organic compounds.  
Nowadays available organic N−F fluorinating agents for electrophilic fluorination have 
the advantage that they are solid, more or less stable and easy to handle. There are 
different classes commercially available, e.g. N-fluoropyridinium salts63, N-
fluorobenzenesulfonimides64 and 1,4-diazabicyclo[2.2.2]octane salts65. From the last 
group mentioned, a quite low-priced one which became popular recently is 
SelectfluorTM (Figure 24), available from Aldrich company.  
 
 
 
 
 
 
Figure 24: The electrophilic fluorination reagent SelectfluorTM 
 
The electrophilic fluorination of the linear product 19 with SelectfluorTM was first 
attempted under neutral conditions analogous to the literature66, but under these 
conditions there was no fluorination. Trying another instruction67, under basic 
conditions (solvent: THF/DMF, base: NaH) the fluorination worked (Figure 25). The 
byproduct 26 with the fluorinated benzyl position is visible in the 19F and 1H NMR 
spectra. The chromatographed product 7 was always contaminated with at least 3% of 
byproduct 26.  
 
 
 
 
 
Figure 25: Electrophilic fluorination of linear compound 19 
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In contrast to the linear compound 19, the fluorination of the cyclic ß-keto esters 22 and 
25 worked smoothly under neutral conditions analogous to the literature (Figure 26) 66.  
 
 
 
 
 
 
 
Figure 26: Fluorination of cyclic compounds 22 and 25 
 
 
3.2.3 Synthesis of 2-fluoro-1-tetralol  
 
2-Fluoro-1-tetralol was found as a byproduct in the decarboxylation of benzyl 2-fluoro-
1-tetralone-2-carboxylate 11. It was synthesised in order to have it in a sufficient 
amount and puritity to establish analysis and quantitative HPLC. Therefore, 2-fluoro-1-
tetralone 12 was reduced with NaBH4 to obtain the desired alcohol 27 (Figure 27) 68. 
 
 
 
 
 
Figure 27: Synthesis of 2-fluoro-1-tetralol 27 
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3.3 Synthesis of the catalysts 
 
3.3.1 Synthesis of amides of 9-amino(9-deoxy)epicinchonine  
The amides were prepared in two steps (Figure 28). In the first step, 9-amino(9-
deoxy)epicinchonine 2951 was prepared from cinchonine 28 via a Mitsunobu reaction 
leading to an inversion at C9. Amine 29 was then converted to amides 30–40 using the 
appropriate acid chlorides analogous to the literature25. Amides 30, 31 (ref. 51) and 32–
35 (ref. 25) are known. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28: Preparation of amides 30–40 
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3.3.2 Further derivatives  
 
Besides carboxylic acid amides, further derivatives have been synthesised. For two of 
these derivatisations, 3,5-di-tert-butylbenzenesulfonyl chloride 4269 was used. It was 
derived by ipso-substitution of 1,3,5-tri-tert-butylbenzene which was treated with 
chlorosulfonic acid (Figure 29). 
 
 
 
 
Figure 29: Preparation of 3,5-di-tert-butylbenzenesulfonyl chloride 42. 
 
3.3.2.1 Derivatives of  9-amino(9-deoxy)epicinchonine 
 
The amino group of 29 was derivatised in a couple of ways. Structurally familiar to the 
carboxylic acid amides, sulfonamides 43 and 44 were prepared (Figure 30) 70. N-(9-
Deoxyepicinchonine-9-yl)-2,4-dinitrophenylamine 45 was synthesised by nucleophilic 
aromatic substitution with Sangers reagent 2,4-dinitrofluorobenzene. Another 
derivatisation of the amino group of 29 was carried out with phenylisocyanate, arriving 
at N-(9-deoxyepicinchonine-9-yl)-N’-phenylurea 46.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30: Preparation of sulfonamides 43 and 44, amine 45 and urea derivative 46 
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3.3.2.2 Derivatives of  cinchonine 
 
The hydroxy group of cinchonine 28 was derivatised with phenylisocyanate obtaining 
cinchonine-9-yl phenylcarbamate 4771 (Figure 31). Cinchonine-9-yl-3,5-di-tert-
butylbenzenesulfonate 48 was prepared analogous to a described tosylation51.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31: Preparation of carbamate 47 and sulfonate 48 
 
3.3.2.3 Derivative of  quinidine 
 
The intramolecular ether ß-isocupreidine 5072 was formed in one step by refluxing 
quinidine 49 in concentrated H3PO4 with KBr (Figure 32). This derivative proved to be 
a successful catalyst in the Baylis Hillmann reaction.  
 
 
 
 
 
Figure 32: Synthesis of ß-isocupreidine 50 
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3.3.3 1H NMR analytics  
 
The sulfonamides 43 and 44 gave unexpectedly complicated 1H NMR spectra in CDCl3 
at room temp. Signals which belong to one proton splitted in two signals with a ratio of 
1 to 0.4. The reason for this phenomenon is the hindered rotation around the S-N bond 
due to a partial double bond character (Figure 33). Usually, the elements of the third and 
higher periods exhibit much lower tendencies to π-bonding. Therefore, the rotation 
barriers  
 
 
 
 
 
Figure 33: Resonance forms of benzene-sulfonamide moiety 
 
in the sulfonamides should be much lower than those of the carboxylic amides. In 
contrast to that, the sulfonamides 43 and 44 of 9-amino(9-deoxy)epicinchonine showed 
hindered rotation in 1NMR, while the familiar carboxyl amides do not. The 
phenomenon of hindered rotation about S-N bonds was recently reported for N,N-
disubstituted sulfonamides73,74. With N-(9-deoxyepicinchonine-9-yl)-4-
methylbenzenesulfonamide 43 a 1H NMR spectra in C2D2Cl4 was recorded in the 
temperature range from 27–115 °C (Figure 34). At 27 °C it can be seen that not only the 
protons of 4-methylbenzene (normally an AA´BB´ spectra) are affected from the slow 
exchange, but also the protons of the quinoline ring. It is observable that there is 
coalescence at 80 °C with broad peaks. At 110 °C the exchange is fast enough to 
sharpen the signals and interpretation can be done analogous to the carboxylic amide 
derivatives. A comparison between the spectra of sulfonamide 43 and the corresponding 
benzamide 39 shows the analogy of the spectra  (Figure 35). The three signals with the 
highest δ values in the low field region belong to the quinoline ring protons H2’, H5’ 
and H8’. The amide proton NH gives a broad signal which is not always visible. 
Characteristic  from their appearance and location are the multiplets of  H6’ and H7’. 
The signal of H3’ is the one with the lowest δ value of the quinoline protons. For both 
substances, the AA’BB’ system of H2’’/H6’’ and H3’’/H5’’ of the para-substituted 
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benzene residue is obvious. Typical for all cinchona alkaloid derivatives are the ddd 
signal of H10 and the two pseudo-triplets of doublets for H11. The coupling pattern of 
H11 arises from the coupling with H10, H3 and the other geminal H11 proton. As the 
geminal coupling with the other H11 proton and the long-range coupling with H3 have 
the same values, the signal of H11 appears as a pseudo-triplet of doublet. Due to 
dynamic effects, the signal of H9 is very broad. Because of their proximity to the 
electronegative nitrogen, the protons H2, H6 and H8 are those with the highest ppm 
values of the quinuclidine framework. Proton H3 always shows up as a single multiplet. 
Protons H4, H5 and H7a mostly overlap to one multiplet. The signal with the highest 
shift is the one of H7b.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34: Coalescence spectra of N-(9-deoxyepicinchonine-9-yl)-4-methylbenzene- 
                  sulfonamide 43 
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Figure 35: 1H NMR of sulfonamide 43 (400 MHz, C2D2Cl4, 110 °C) and   
                   carboxylamide 39 (300 MHz, CDCl3, 27 °C) 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
H2’ H5’ H8’NH
H2’’, H6’’,
H7’
H3’’, H5’’,
H3’
H6’
CDCl3 H10 H9
H11a, H11b
H2, H6, H8
H O2
H3
H4, H5, 
H7a
-CH3
H7b
 
(ppm)
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
H2’
H5’
H8’
H7’
H6’
H2’’, H6’’, 
H3’
H3’’, H5’’
H10 H11a
H2, H6, 
H8
H2
-CH , H33
H4, H5
H7a H7b
H11b
H9
C D Cl2 2 4
acetone
N
N
HN 8
9
2'
3'
8'
7'
6'
5'
2
3
10
11a11b
4
7
5 6
3''
2''
S OO
5''
6''
N
N
HN
O
8
9
2'
3'
8'
7'
6'
5'
2
3
10
11a11b
4
7
5 6
3''
2''
6''
5''
Catalysis 
 
 
26
4 Catalysis 
 
 
4.1 Overview on the applied catalysts 
 
In addition to the already introduced self-synthesised catalytically active bases, further 
derivatives have been tested. Therefore, all catalysts employed in the different catalytic 
systems described in this chapter are displayed in Figure 36 and 37. The commercial 
cinchona alkaloids were purchased from Merck and Fluka. Amide derivatives 5332 and 
54–6325 were available from previous studies.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36: Commercial cinchona alkaloids and amide derivatives of 9-amino(9-                  
deoxy)epicinchonine 
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Further already available catalysts were 6425, 6730 and 68, 6975. (-)-Ephedrine 65 and  
(-)-norephedrine 66 were purchased from Acros.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 37: Further cinchona alkaloid derivatives and ß-aminoalcohols 
 
For easier reading of the tables, the residues of the N-(9-deoxyepicinchonine-9-yl)amide 
derivatives was abbreviated with ECA (Figure 36), the 9-amino(9-deoxy)epicinchonine 
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4.2 Enantioselective decarboxylation leading to α-amino acid  
      derivatives 
 
 
 
While there are many asymmetric syntheses leading to enantiopure α-amino acids,76,77 
examples for catalytic enantioselective decarboxylation are rare, not taking into account 
enzymatic decarboxylation reactions. An approach was made with trans-dichloro 
cobalt(III) complexes, which needed stoichiometric amounts of the complex. 
Furthermore, the procedure was quite complicated78,79,80. In contrast, the catalysis 
described here only needs substoichiometric amounts of catalyst and is easy to carry 
out. 
 
4.2.1 General standard procedure  
 
The racemic 2-N-acetylamino-2-alkylmalonic acid monoethyl esters 1–3 (0.74 mmol) 
and 10 mol% optically active base were  stirred in 9 mL abs. THF at 70 °C under 
nitrogen. After 24 h the reactions were stopped by cooling and evaporating the solvent 
at room temp. The residue was dissolved in diluted hydrochloric acid and extracted with 
ethyl acetate. The base stayed in the water phase and could be recycled. The organic 
layer was evaporated and the conversion was determined by 1H NMR spectroscopy. 
Usually, conversion was quantitative.  
 
 
4.2.2 The alanine system 
 
4.2.2.1 First testings  
 
The optimum conditions for this system, a reaction temperature of 70 °C and THF as 
solvent,  have been elaborated in my previous work32. Furthermore, hemiester 1 had  
turned out to be the best substrate. The diacid 2-N-acetylamino-2-methylmalonic acid 
and the nitrile derivative 2-N-acetylamino-2-cyanopropionic acid had given poor results 
in first testings. Therefore, 2-N-acetylamino-2-ethoxycarbonylpropionic acid 1 was 
chosen as substrate further testings. 
Catalysis 
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Figure 38: Decarboxylation leading to ethyl N-acetylalaninate 4 
The results with the commercial cinchona alkaloids 28, 49, 51 and 52 under standard 
conditions are given in entries 1–4 of Table 1. Obviously, the configurations at positions 
8 and 9 of the cinchona alkaloid and the prescence or absence of the methoxy group in 
6’-position of the quinoline ring determine the direction of induction. With respect to 
positions 8 and 9, cinchonine 28 and cinchonidine 51 as well as quinidine 49 and 
quinine 52 are mirror image isomers. Consequently, cinchonine 28 and cinchonidine 51 
(entries 1 and 2) as well as quinidine 49 and quinine 52 (entries 3 and 4) gave different 
configurations of product 4. On the other hand, the pairs cinchonine 28/quinidine 49  
Table 1: First tested catalysts (THF, T = 70 °C, t = 24 h, 100% conversion) 
Entry Base (10 mol%) ee [%] of 4 configuration 
1 cinchonine 28 9.6; 9.0; 9.0 D 
2 cinchonidine 51 4.8; 5.0 L 
3 quinidine 49 4.2; 4.0 L 
4 quinine 52 5.6; 6.2 D 
5 2-EtO-Ph-ECA 53 18.4; 18.6 L 
 
and cinchonidine 51/quinine 52 have the same configurations at position 8 and 9. They 
just differ in the absence or presence of a methoxy group in the quinoline system. 
Surprisingly, the components of the pairs afforded opposite configurations in product 4. 
N-(9-Deoxyepicinchonine-9-yl)-2-ethoxybenzamide (53), the best base in the 
Naproxen® system25,26, gave better enantioselectivities than the commercially available 
alkaloids (entry 5). 
 
 
4.2.2.2 Screening of bases 
 
Since benzamides of the cinchona alkaloids had been the best bases in decarboxylation 
reactions of the Naproxen® system25,26, in addition to benzamide 53, further amides 
were screened as catalysts in the decarboxylation of hemiester 1.  
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In the decarboxylation of hemiester 1 to the acetylated alanine ester 4, the unsubstituted 
benzamide 30 gave promising results with about 50% ee (Table 2, entry 1). The ortho-, 
meta- and para-methoxy substituted benzamides 32–34 were tested to see whether there 
were steric and electronic effects. In fact, the ortho-substituted derivative 32 afforded 
only about 18% ee (entry 2) compared to the meta- and para-substituted derivatives 33 
and 34 with about 52% ee (entries 3 and 4) indicating steric hindrance of ortho-
substituents. This was corroborated by the low enantioselectivities of the ortho-ethoxy 
derivative 53 and the ortho-fluoro derivative 54 (Table 1, entry 5; Table 2, entry 7). 
Table 2: Testing of amide derivatives (THF, T = 70 °C, t = 24 h, 100% conv.)                
Entry Base (10 mol%) ee [%] of 4, L-config. 
1 Ph-ECA 30 48.2; 51.6 
2 2-MeO-Ph-ECA 32 16.7; 19.3 
3 3-MeO-Ph-ECA 33 52.0; 52.2 
4 4-MeO-Ph-ECA 34 49.9; 52.2 
5 4-tert-butyl-Ph-ECA 39 53.9; 54.2 
6 3-ECA-Ph-ECA 31 43.8; 44.4 
7 2-F-Ph-ECA 54 26.5; 29.6 
8 3,5-di-F-Ph-ECA 36 53.9; 54.2 
9 3,5-di-MeO-Ph-ECA 37 52.1; 53.7 
10 3,5-di-NO2-Ph-ECA 38 49.6; 50.8 
11 3,5-di-tert-butyl-Ph-ECA 35 58.0; 59.6 
12 1-naphtyl-ECA 55 29.3; 35.7 
13 2-naphtyl-ECA 56 44.1; 39.9 
14 2-furanyl-ECA 57 44.5;46.7 
15 ferrocenyl-ECA 58 53.2; 54.0 
16 α-methylcinnamic-ECA 59 42.3; 49.8 
17 1,1-di-Ph-CH-ECA 60 24.6; 26.8 
18 isopropyl-ECA 61 24.5; 24.7 
19 cyclohexyl-ECA 62 24.0; 25.8 
20 adamantyl-ECA 40 8.0; 6.0 
21 (1S)-camphane-ECA 63 4.2; 4.9  
 
39 with a tert-butyl group in para-position gave 54% ee (entry 5) and the dibenzamide 
31 44% ee (entry 6). Compounds 36, 37, 38, containing strongly electron-withdrawing 
and electron-attracting substituents in 3,5-position led to an enantiomeric excess in a 
range between 50 and 54% ee (entries 8–10), showing that there was no pronounced 
inductive effect. N-(9-Deoxyepicinchonine-9-yl)-3,5-di-tert-butylbenzamide (35) 
afforded the best result (59% ee) in this series (entry 11).  
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As expected on the basis of the steric hindrance argument, the 1-naphthyl derivative 55 
gave a lower ee than the 2-naphthyl derivative 56 (entries 12 and 13). The 2-
furanylamide 57 and the ferrocenylamide 58 provided similar results as the parent 
benzamide 30 (entries 14 and 15).  
Amides lacking the aromatic substituent were much less efficient in the decarboxylation 
of 1. While the α-methylcinnamic acid amide 59 yielded about 45% ee (entry 16), the 
aralkyl and alkyl derivatives 60–63 and 40 afforded only low enantioselectivities 
(entries 17–21) including the adamantane derivative 40 and the (1S)-(–)-camphanic acid 
derivative 63 in which even group R was chiral. 
In addition, further cinchona alkaloid derivatives 43–48, 64 and 50 were tested in the 
decarboxylation of hemiester 1. Similar to the phenyl- and di-tert-butylphenyl-
substituted benzamides 30 and 35, the corresponding sulfonamides 43 and 44, derived 
from 9-amino(9-deoxy)epicinchonine (29), afforded 55 and 52% ee (Table 3, entries 1 
and 2).  
 
Table 3: Decarboxylation of 1 with cinchona alkaloid derivatives 43–48, 64 and 50  
              (THF, T = 70 °C, t = 24 h, 100% conversion) 
Entry Base (10 mol%) ee [%] , L-config. 
1 tosyl-AEC 43 53.9; 55.6 
2 3,5-di-tert-butyl-Ph-SO2-AEC 44 51.0; 52.7 
3 2,4-di-fluoro-Ph-AEC 45 2.5; 3.6 
4 phthalimide-AEC 64 0.8; 2.4 
5 PhNHCO-AEC 46 28.2; 32.5 
6 PhNHCO-cinchonine 47 17.2; 18.0 
7 3,5-di-tert-butyl-Ph-SO2-cinchonine 48 6.5; 6.7 
8 ß-isocupreidine 50 20.4; 22.1 
 
Amine 45 and phthalimide 64 gave poor results (entries 3 and 4), whereas the urea 
derivative 46 led to 30% ee (entry 5). The carbamate and sulfonate esters 47 and 48 of 
cinchonine achieved only low enantioselectivities as did ß-isocupreidine 50 (entries 6, 7 
and 8).  
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4.2.2.3 Further variations 
 
With 53, the effect of varying the amount of catalyst in the decarboxylation of hemiester 
1 was tested (Table 4, entries 1–8). Increasing the amount of 53 gave rise to an increase 
of the enantiomeric excess, reaching 41.5% ee with 60 mol% base (entry 7). Use of a 
stoichiometric amount of base did not change the results (entry 8). In contrast, with 35 
the enantiomeric excess could not be improved with higher amounts of base (entries 9 
and 10). Interestingly, with 60 mol% of the  3,5-di-methoxy substituted amide 37 and 
the 3-methoxy substituted benzamide 33 enantiomeric excess increased to about 66 % 
(entry 11 and 12). A decrease of the reaction temperature to 30 °C with base 35 made 
the reaction sluggish. After 18 days there was only 85% conversion with decreased 
enantioselectivity (entry 13). 
 
Table 4: Variation of catalyst concentration and temperature in the decarboxylation of  
    1→4 (100% conversion except for entry 13: 85%)  
Entry Base mol% 
base 
T [°C] t 
[h] 
ee [%] of 4, 
L-config. 
1 2-EtO-Ph-ECA 53 5 70 24 8.1 
2 53 10 70 24 18.5 
3 53 20 70 24 23.5 
4 53 30 70 24 27.7 
5 53 40 70 24 31.2 
6 53 50 70 24 34.4 
7 53 60 70 24 41.5 
8 53 100 70 24 42.4 
9 3,5-di-tert-butyl-Ph-ECA 35 30 70 24 62.8 
10 35 60 70 24 60.2 
11 3,5-di-MeO-Ph-ECA 37 60 70 24 65.9 
12 3-MeO-Ph-ECA 33 60 70 24 65.5 
13 3,5-di-tert-butyl-Ph-ECA 35 10 30 432 53.6 
 
 
4.2.2.4 Kinetic study 
 
A kinetic study of the decarboxylation of 1 was performed with base 27, which had 
been the most successful catalyst in the system 1→4. The twelvefold standard reaction 
was analyzed taking samples each hour. Conversion was almost complete after 12 hours 
(Figure 39). At the beginning of the catalysis the enantiomeric excess of ethyl N-
acetylalaninate (4) was a little lower. After 5 h it reached 60% ee and stayed constant 
then. A similar observation had been made in the Naproxen® system25. This is in 
contradiction to a recently published computational study53, denying a two-step 
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decarboxylation/protonation mechanism and suggesting a concerted mechanism 
according to which each enantiomer of the starting material transforms into its own 
product enantiomer. In such a case, kinetic resolution should occur. This was not 
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Figure 39: Kinetics of the decarboxylation of 1→4 with base 35 
 
observed, neither in the Naproxen® system25 nor in the present study. Moreover, in the 
Naproxen® system it had been shown that both enantiomers of the resolved starting 
material 2-cyano-2-(6-methoxynaphth-2-yl)propionic acid gave the same product 
enantioselectivity of about 68% ee, which is incompatible with a concerted mechanism. 
Therefore, the two-step decarboxylation/protonation mechanism via planar 
intermediates, such as the enolate of ethyl N-acetylalaninate in the decarboxylation of 1, 
and their stereoselective protonation, is plausible. 
 
 
4.2.3 The valine system 
The screening was extended to the decarboxylation of 2 affording valine derivative 5 
(Figure 40). With the unsubstituted benzamide 30 15% ee was obtained (Table 5, entry 
1). Again the ortho-methoxy-substituted base 32 gave a bad result, in this case a 
racemate (entry 2), whereas the meta- and para-derivatives 33 and 34 matched the 
unsubstituted benzamide 30 with about 13% ee (entries 3 and 4). 
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Figure 40: Decarboxylation leading to ethyl N-acetylvalinate 
An increase to 48% enantiomeric excess was observed with N-(9-deoxyepicinchonine-
9-yl)-2,5-di-tert-butylbenzamide (35) (entry 5), also the best base in the system 1→4. 
 
Table 5: Decarboxylation of 2 with different bases (THF, T = 70 °C, t = 24 h, 100%  
    conversion) 
Entry Base (10 mol%) ee [%] of 5, L-config. 
1 Ph-ECA 30 14.2; 15.6 
2 2-MeO-Ph-ECA 32 rac. 
3 3-MeO-Ph-ECA 33 9.7; 13.2 
4 4-MeO-Ph-ECA 34 11.8; 13.7 
5 3,5-di-tert-butyl-Ph-ECA 35 48.0 
 
 
4.2.4 The phenylalanine system 
 
Enantioselectivities were generally high in the decarboxylation of 3 to give ethyl N-
acetylphenylalaninate 6. The unsubstituted benzamide 30 afforded 67% ee (Table 6, 
entry 1). Again, the ortho-substituted methoxybenzamide 32 gave only 38% ee (entry  
 
 
 
Figure 41: Decarboxylation leading to ethyl N-acetylphenylalaninate 
2), whereas the meta- and para-substituted methoxybenzamides 33 and 34 achieved 
65% and 70% ee (entries 3 and 4). With 39 and 35 close to 70% ee were obtained 
(entries 5 and 6). The sulfonamides 43 and 44 resulted in 63% and 65% ee (entries 7 
and 8).  
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Table 6: Decarboxylation of 3 with different bases (THF, T = 70 °C, t = 24 h, 100%  
                conversion) 
Entry Base (10 mol%) ee [%] , L-config. 
1 Ph-ECA 30 65.7; 69.0 
2 2-MeO-Ph-ECA 32 37.1; 37.8 
3 3-MeO-Ph-ECA 33 63.7; 65.4 
4 4-MeO-Ph-ECA 34 69.3; 71.1 
5 4-tert-butyl-Ph-ECA 39 67.3; 69.1 
6 3,5-di-tert-butyl-Ph-ECA 35 65.8; 67.7 
7 tosyl-AEC 43 62.4; 63.6 
8 3,5-di-tert-butyl-Ph-SO2-AEC 44 64.1; 64.7 
 
 
 
 
4.2.5 Analytics 
 
Conversion was monitored with TLC (SiO2) using EtOAc as eluent. Compounds 1–6 
were made visible by heating with molybdatophosphoric acid (for 3 and 6 UV worked 
also). For exact conversion control by 1H-NMR, the singlet of the acetyl group of the 
starting material was compared to that of the product (data see experimental part). 
Samples with incomplete conversion have to be chromatographed on SiO2 with EtOAc 
in order to remove the starting material.  
 
The determination of the enantiomeric excess in the decarboxylation of 2-N-
acetylamino-2-alkylmalonic acid ethyl esters was achieved with gaschromatography. 
With a chiral capillary column all enantiomers can be separated. An exact baseline 
separation was possible. Repeated injections gave similar results. The enantiomeric 
excess can be calculated from the peak areas A:  
 
 SR
SR
A A
A A
    100  =  [%] ee +
−×
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For example, Figure 42 shows a cutout of the chromatogram of  
the catalysis leading to ethyl N-acetylphenylalaninate 6. The  
area ratio corresponds to an enantiomeric excess of 62.4% ee.  
The signal with the longer retention time was assigned to  
the L enantiomer by optical rotation measurements  
of an enantiomerically enriched sample of 681.                                                                                           
                                                                                           
 
      
 
 
 
Figure 42: GC cutout of a sample of     
                  6 with 62.4% ee 
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4.3 Enantioselective decarboxylation leading to α-fluoro  
      ketones 
 
 
 
The synthesis of cyclic and acyclic chiral fluoro-organic compounds is an important 
topic in modern pharmaceutical and agricultural chemistry82,83. Furthermore, chiral α-
fluoro ketones are useful for the asymmetric epoxydation of alkenes84. The generation 
of quaternary stereogenic fluoro centres in carbonyl α-position is now well developed, 
but at least a stoichiometric amount of a chiral fluorinating agent85,86,87,88,89 or chiral 
substrate is required90. Catalytic methods consist of asymmetric alkylation of racemic 
α-fluoro carbonyl compounds under phase-transfer conditions91,92,93 and fluorination of 
ß-keto esters activated by chiral Lewis acid-TADDOL-complexes94 or in the presence 
of chiral palladium complexes95. The enantioselective formation of a tertiary fluoro 
centre α to a carbonyl group is problematic since most of the above methods work in 
media which are not neutral enough to avoid racemisation of the newly fluorinated 
carbon with enhanced acidity. Thus, only strategies starting from compounds having 
chiral protective groups are available for this purpose96,97.  
 
The employment of the palladium-induced cascade reaction (Figure 43) is another 
approach to tertiary α-fluoro ketones. In contrary to the α-amino acid systems 
introduced in the last chapter, the deprotection of the benzyl ester A to the free acid B 
initiates the ultimate decarboxylation step to arrive at the desired α-fluoro ketone D via 
enolic species C.  
 
 
 
 
 
Figure 43: The three steps of the Pd-induced cascade reaction  
 
 
 
 
R1
R2
O Ph
O O
F
R1
R2
O
F*Pd/C and H2
  toluene
R1
R2
OH
O O
F
base [base-H]+ [base-H]
+ base
CO2
A B C D
R1
R2
O-
F
Catalysis 
 
 
38
An advantage of the deprotection step is that the amount of substrate is propably kept 
low compared to the amount of chiral base. Furthermore, even sensitive ß-oxo acids B 
which are not stable as free acids can be applied in the protected form. However, 
heterogeneous catalytic systems may bear reproducibility problems and the supporting 
material plays an important role98. In the special case of this cascade reaction it was 
found that the kind of Palladium on charcoal has a strong influence on the enantiomeric 
excess29.  
 
 
4.3.1 General standard procedure  
 
Employing the catalytic cascade reaction in order to obtain optically active fluoro 
ketones, the substrate (0.17 mmol) and the chiral base (30 mol%) were dissolved in 
MeCN (10 mL). Then the Pd catalyst (2.5 mol%) was added and the hydrogen 
atmosphere was provided with a gasbag. After the time indicated, the reaction mixture 
was filtered through 10 cm of Celite 545 (washed with CH2Cl2) in order to remove the 
Pd on charcoal. The solvents were evaporated at room temp. To remove the base, the 
residue was filtered through a small SiO2 column with CH2Cl2.  
 
 
4.3.2 The 2-fluoro-1,2-diphenylethanone system 
 
Starting from the linear compound 7 in the first experiments with Pd/C type 5011 from 
Engelhard, full defluorination was observed with the achiral base 2-(methylamino)-
ethanol) leading to deoxybenzoin 70 as product (Figure 44). This was unexpected as the 
C-F bond is usually stable towards hydrogenolysis with Pd catalysts, but the presence of 
a base and the benzylic position of the fluorine atom facilitate dehalogenation99. 
 
 
 
 
 
Figure 44: Full defluorination of 2-fluoro-1,2-diphenylethanone  
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4.3.3 Defluorination of α-fluoro ketones 
 
Compared to other halogen compounds, fluorinated substances are the most stable ones, 
as the order of reactivity is RF << RCl < RBr < RI. Nevertheless, defluorination by 
hydrogenolysis is possible, depending on the position of fluorine in the molecule and on 
the conditions. Concerning the conditions, it generally can be said that the presence of a 
base in the reaction mixture and the use of a polar, hydroxylic solvent facilitate carbon-
halogen cleavage99.  
 
In the special case of defluorination, the position of the fluorine is important. Allylic, 
vinylic, benzylic and aromatic fluorides are relatively easy to hydrogenolyse. A 
mechanism with participation of π bonds is proposed for that phenomenon100. The 
carbon-fluorine rupture requires 107–116 kcal/mol, the carbon–chloride bond 
dissociation energy is only 60–84 kcal/mol. While the hydrogenolysis of sp3 carbon-
fluorine bonds usually requires drastic conditions, it works at mild conditions (room 
temp., atmospheric hydrogen pressure) for allylic, vinylic, benzylic and aromatic 
fluorine atoms.  
 
Defluorinations of compounds containing a fluorine in benzyl position, such as 7, are 
known to literature100. However, they were carried out in the protic solvents methanol or 
ethanol. Therefore, the defluorination of 7 was not expected in the aprotic solvent 
acetonitrile. The proposed participation of the π system of the aromatic ring, which 
accounts for easy hydrogenolysis of benzylic fluorine, is illustrated for 1,1-difluoro-1,2-
diphenylethane (Figure 45)100. 
 
 
 
 
 
 
 
 
Figure 45: Defluorination of 1,1-difluoro-1,2-diphenylethane  
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Reports on hydrogenolysis of fluorine in α-fluoro ketones are quite rare. In these cases, 
the π bond between carbon and oxygen participates in the cyclic mechanism100. When 
2-fluoro-1-phenylethanone was hydrogenated in order to obtain 2-fluoro-1-
phenylethanol, it appeared that this reaction only worked smooth if the starting material 
was carefully purified and there were no traces of acid (Figure 46)101. Otherwise, 
defluorination arriving at 1-phenylethanol took place. On the other hand, under the 
same conditions, no defluorination occurred with 1-phenyl-2-fluoroethanol as starting 
material. 
 
 
 
 
 
 
 
 
 
Figure 46: Defluorination of 2-fluoro-1-phenyl-ethanone 
 
This example of an α-fluoro ketone affects our catalytic systems. Therefore, a partial 
dehalogenation cannot be excluded, although the solvent used is not the same (e.g., the 
reaction described above was slower in methanol). One last example should show that 
the α-fluoro ketone function will not inevitably promote defluorination. The catalytic 
hydrogenation of α,ß-unsaturated α-fluoro aldehydes, ketones and esters gave 
exclusively the α-fluoro ketones A in the case of an alkyl group for R and R´ (Figure 
47)102. But in the case of a phenyl group for R or R´, the defluorinated byproduct B was 
found in 23-60% yield. This example is interesting as the substrate has a second  
 
 
 
 
 
 
Figure 47: Hydrogenation of α,ß-unsaturated α-fluoro carbonyl compounds 
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functionality, the vinyl system, which facilitates the cleavage of the C–F bond. 
However, it does not defluorinate except if there is a phenyl group in R or R´ position. 
Before HUDLICKY proposed a concerted mechanism to explain the readiness of the 
hydrogenolysis in allylic and vinylic fluorides103,104, he stated something very suitable 
for the defluorination in an earlier review: “…it is very difficult to draw any 
conclusions as to whether a fluorine atom will stand the hydrogenation, or be replaced 
by hydrogen. The author´s impression is that in this respect fluorine behaves just in the 
opposite way one expects or desires”105. 
 
Another route which enables defluorination is photoreduction. For the cyclic α-
fluoroketones 2-fluoro-cyclohexanone 10 and 2-fluoro-1-tetralone 12, photochemical 
induced defluorination was reported106,107.  
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4.3.4 The 2-fluorocyclohexanone system 
 
With 9 another problem emerged, since the reaction product 2-fluorocyclohexanone 10 
was too volatile for work-up. Furthermore, HPLC detection was another difficulty. 
Therefore, this system was not further pursued.  
 
 
 
 
 
Figure 48: The 2-fluoro-cyclohexanone system 
 
 
4.3.5 The 2-fluoro-1-tetralone system 
 
Benzyl 2-fluoro-1-tetralone-2-carboxylate 11 was a suitable starting material for our 
studies. When submitted to the above conditions, the expected 2-fluoro-1-tetralone 12 
was isolated besides small amounts of tetralone 23, the defluorination product, and 2-
fluoro-1-tetralol 27 coming from the overreduction of 12 (Figure 49). The relative 
quantities of each product and the ee of 12 are strongly dependent on the conditions. 
 
Figure 49: Catalysis with benzyl 2-fluoro-1-tetralone-2-carboxylate 11 
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Especially the nature of the catalyst, palladium on charcoal, is crucial. The different 
surface properties and Pd and the H2O content are sufficient to induce great differences 
in reactivity or enantioselectivity. For example, with the usually employed 5% Pd/C 
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28 to 66%, in the presence of quinidine as a base, at the same time the yield of 23 was 0 
to 30%). Therefore, other Pd/C catalysts were tested. Pd/C Engelhard 5067 was tried, 
first delivering good results (Table 1, entry 1), later again causing reproduction 
problems. For this reason, Pd/C Fluka 75992 and 75990 were tested (entries 2 and 3) 
with inferior results to Pd/C Merck 807104 (entry 4). This type brought constant and 
reproducible results, only in a few cases the ee dropped. With Pd(0) gained by  PdCl2 
reduction, the reaction rate was low (entry 5). The cleavage of the benzyl ester can also 
be achieved by the Wilkinson catalyst using a silane as hydrogen source109. However 
the homogeneous catalysis conditions with elemental hydrogen resulted in a low 
reaction rate and the ee dropped dramatically (entry 6). Therefore, further catalyses 
were performed with Pd/C type 807104 from Merck. 
 
Table 7: Influence of the supported catalyst. Conditions: MeCN, rt., 30 mol% quinine  
    52, H2 delivered by a gasbag, except entry 6 (40 bar). 
a traces: < 0.4 % 
 
 
4.3.5.2 Testing of different chiral bases  
 
Aminoalcohols like 65–67 led to good results in asymmetric protonation of tetralone 
enolic species27,28,29 and they were tested first in our experiments (Table 8). However, 
bases 65–67 and aminoalcohols 68, 69, are ineffective with fluoro compound 11 (entries 
1–5). Poor enantioselectivities of fluorotetralone 12 were observed and high amounts of 
tetralone 23 were found in most cases. Employing the natural cinchona alkaloids 28, 51, 
49 and 52 to the catalysis, promising high stereoselectivities with up to 65% ee were 
obtained (entries 6–9). Besides, only little defluorination occurred with them.  
 
Products 
 
Entry Catalyst 
(mol%) 
t 
[h] 
12 (%) 23(%) ee of (S)-12 
(%)  
1 5%Pd/C Engelhard 5067110 (2.5) 1 96; 94 4; 6 62.6; 56.9 
2 5% Pd/C Fluka 75992111 (2.5) 1 98; 99 2; 1 63.1; 59.9 
3 10% Pd/C Fluka 75990112 (2.5) 1 98; 92 2; 8 50.7; 65.6 
4 10% Pd/C Merck 807104113 (2.5) 1 95; 74 tracesa 66.0; 67.9 
5 Pd (0) (from PdCl2) (25) 2 14; 17 traces 59.8; 51.2 
6 Rh(PPh3)3Cl (2.5) 2 2; 2 traces 20.5; 18.3 
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Table 8: Variation of the chiral base. Conditions:  Pd/C Merck 807104 (2.5 mol%),  
    base (30 mol%), MeCN, rt., H2 delivered by a gasbag. 
a traces: < 0.4% 
b n.d.: not detected at λ = 254 nm. 
 
As commercial cinchona alkaloids delivered fruitful results, different derivatives of 
their framework were tested with good catalytic performances in other decarboxylation 
systems25. Examination of the results (entries 10–19) shows that with these bases as 
inductors only little defluorination and overreduction occurred. However, no base was 
found superior to quinine. The exchange of the hydroxyl group at C-9 by an amino 
group resulted in a decreased enantiomeric excess of 19% (entry 10). Whatever the 
substitution at this amino group was, enantioselectivity reached not more than 25% 
(entries 11-17). The transformation of the C-9-hydroxyl function into carbamate 47 or 
ß-isocupreidine 50 gave also disappointing results (entries 18, 19). 
 
 
Products 
 
Entry 
 
Base 
[30 mol%] 
 
 
t 
[h] 12  
(%) 
23 
(%) 
27  
(%) 
ee of 12 
(%) (config.) 
1 (-)-ephedrine 65 0.5 60; 74 40; 26 n.d.b 1.5; 1.7 (R) 
2 (-)-norephedrine 66 0.5 71; 71 29; 29 n.d. 0.6; 1.1 (R) 
3 (+)-aminoborneol 67 0.5 69; 73 31; 27 tracesa 0 
4 (-)-phenylglycinol 68 0.5 52; 71 1; 5 n.d.; 1 3.4; 0.8 (S) 
5 (+)-tert-leucinol 69 0.5 40; 53 60; 46 n.d.; 1 0.6; 1.3 (S) 
6 cinchonine 28 2 97; 98 3; 3 traces; 
n.d. 
51.4; 51.5 (R) 
7 cinchonidine 51 2 95; 97 5; 3 n.d.; 0 50.0; 50.1 (S) 
8 quinidine 49 2 99; 87 traces; 13 0 ; n.d. 64.7; 64.8 (R) 
9 quinine 52 2 94; 93 6; 7 n.d.; n.d 62.5; 64.4 (S).
10 H-AEC 29 2 96; 95 2; 2 0; 0 20.4; 17.9 (S) 
11 tosyl-AEC 43 2 95; 94 1; 1 4; 5 24.1; 14.7 (S) 
12 2,4-di-nitro-AEC 45 2 86; 85 3; 2 0; 0 6.7; 1.5 (S) 
13 Ph-ECA 30 2 97; 93 3; 7 n.d.; n.d. 20.0; 25.1 (S) 
14 2-MeO-Ph-ECA 32 2 96; 97 2; 4 2 ; n.d. 2,7; 2.4 (S) 
15 3-MeO-Ph-ECA 33 2 98; 96 2; 1 n.d.; 3 17.4; 19.4 (S) 
16 4-MeO-Ph-ECA 34 2 98; 95 1; 1 2; 4 24.9; 20.7 (S) 
17 3,5-di-tert-butyl-Ph-ECA 35 2 95; 89 1; traces 4; 2 8.1; 8.0 (S) 
18 PhNHCO-cinchonine 47 2 97; 97 1; 1 2; 2 5.9; 1.7 (S) 
19 ß-isocupreidine 50 2 97; 96 2; 2 1; 2 20.9, 21.1 (S) 
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4.3.6.3 Variations with quinine  
 
As quinine 52 (Table 8, entry 9) delivered the best results, further variations were 
carried out with this base (Table 9). Switching to THF as solvent slightly decreased the 
ee from 65 to 60% (Table 9, entry 1). With EtOAc the enantiomeric excess increased in 
one case, but the result was not reproducible (entry 2). Furthermore, defluorination 
increased in both solvents. At 45 °C, the optical inductions are identical to standard 
conditions, but more defluorination was found (entry 3). At low conversion of the 
substrate (entry 4) as well as at prolonged reaction time of 16 h (entry 5), the ee of 12 
remains about 65%. Under these conditions, compound 12 did not racemise. However, 
the amount of tetralone 23 increased until it became major (91%, entry 6).  Only at this 
long reaction time, the ee of 12 dropped to 8%. At 40 bar in an autoclave, after 15 min 
the enantiomeric excess was similar to the standard catalysis (entry 7). Taking the 
tenfold amount of Pd/C, there was a high degree of defluorination and overreduction. 
The ee dropped to 25% (entry 8). With the threefold amount of quinine, results are 
similar to the standard catalysis (entry 9). It would seem logical to correlate the 
decreasing ee with the liberation of racemizing HF during the defluorination step 
(entries 6, 8), but this was not always the case (entries 1-5, 7, 9). 
 
Table 9: Variation of catalysis parameters. Standard conditions: Pd/C Merck 807104  
               (2.5 mol%); 30 mol% quinine 52; MeCN, rt., H2 delivered by a  
               gasbag, t = 2 h) 
Products 
 
 
Entry 
 
Change /  
Standard conditions 12 
(%) 
23 
(%) 
27 
(%) 
ee of (S)-12 
(%) 
1 solvent: THF 81; 77 11; 23 8; n.d.b 59.0; 61.8 
2 solvent: EtOAc 86; 97 14; 2 n.d.; 1 70.3; 59.2 
3 T = 45 °C 60; 86 32; 14 8; n.d 65.9; 68.0 
4 t = 0.25 h 4; 5 tracesa  0 ; 0 64.4; 66.6 
5 t = 16 h 53; 64 35; 36 12; n.d. 69.8; 51.8 
6 t = 52 h 9  91 n.d. 8.2 
7 H2 Pressure = 40 bar 
t = 0.25 h 
12; 16 traces 0; 0 64.1; 59.9 
8 Pd / C, 25 mol%. 5; 3 57; 62 38; 35 24.6; 26.0 
9 52, 90 mol% 98 2 n.d. 55.0 
a traces: < 0.4% 
b n.d.: not detected at λ = 254 nm. 
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4.3.6.4 Further testings  
 
Further reactions have been carried out in order to get an idea how defluorination to 23 
occurred (Table 10). Stirring enantioenriched 12 under catalysis standard conditions 
(Pd/C, quinine, MeCN, rt.), under hydrogen atmosphere the ee stayed constant, but 1-
tetralone 23 and alcohol 27 were also forming (entry 1). In the same run without 
hydrogen and for a longer reaction time, the ee dropped but no byproduct was formed 
(entry 2). Analogous experiments were performed with racemic 12. Under hydrogen 
atmosphere no enantiomeric excess was detected, but again byproducts 23 and 27 were 
found (entry 3), while no transformation was observed in the absence of hydrogen 
(entry 4). As expected, racemic 11 was stable under standard conditions in the abscence 
of hydrogen (entry 5). From these experiments, it appears that defluorination is 
probably a hydrogenolysis (compare runs 1 and 3) and that the liberated HF did not 
racemise 12. On the contrary, the supported catalyst is racemising even without 
hydrogen (entry 2), probably due to the acidity of the α-H of the α-fluoro ketone. 
 
Table 10: Further experiments (reaction conditions: Pd/C Merck 807104, 30 mol%  
      quinine 52) 
 
Products 
 
Entry 
 
Substrate 
 
H2 
 
t 
[h] 12 
(%) 
23 
(%) 
27 
(%) 
ee of (S)-12
(%) 
1 12 (50%; 55% ee) yes 16 10; 68 74; 25 16; 6 50.6; 53.6 
2 12 (62.6%; 65.9% ee) no  48 100; 100 0; 0 0 ; 0 23.0; 34.5 
3 12 (racemic) yes 16 71; 94 27; 4 2; 2 racemic 
4 12 (racemic) no  16 100; 100 0; 0 0; 0 racemic 
5 11 (racemic) no  48 - - - - 
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4.3.6 Analytics  
 
Conversion was monitored with TLC (SiO2) using PE:EtOAc (90:10) as eluent. Besides 
the byproduct 2-fluoro-1-tetralol 27, all compounds were visible under UV. A 
quantification of the different substances was not possible in 1H NMR if there were 
more compounds than 2-fluoro-1-tetralone 12 and tetralone 23 in the sample. 
 
Therefore, quantitative HPLC performed with 2-methoxynaphthalene as internal 
standard. In order to obtain the calibration factors fi, measurements with a calibration 
solution containing starting material 11 and all 3 possible products 12, 23, 27 were 
made. The calibration chromatogram is shown in Figure 50 (2-fluoro-1-tetralone with 
an ee of 65.3% ee). For the byproduct 2-fluoro-1-tetralol 27, 4 peaks are visible for the 
4 stereoisomers, at 25.8/28.4 min for the cis-isomers, 27.6/30.0 for the trans-isomers. 
The peaks at 27.6 min and 28.4 are not separated, as substance 27 only appeared in 
certain cases in higher amounts.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 50: HPLC-chromatogram  
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The calibration factor fi  gives a relation between mass and peak area of internal 
standard and compound i (formula 1): 
                                          
                                                 (1)                                                    (2) 
 
i   = compounds 11, 12, 23 and 27  A = integral area 
 st = standard (2-methoxynaphthalene)    m = mass [mg] 
 
Formula (2) follows from formula (1) and allows the calculation of the mass mi and 
therefore of the yield.  
 
First HPLC measurements were made at 254 nm detection wavelength. It appeared that 
2-fluoro-1-tetralol 27, which was not found in the 1H NMR of the first catalytic runs, 
could not be detected at 254 nm. After assuring that the new byproduct was 2-fluoro-
tetralol (synthesis by reduction of 2-fluoro-1-tetralone, analytics: mass, 1H NMR, single 
injection HPLC), a suitable detection wavelength for all compounds was found with 210 
nm.  
The assignment optical rotation/configuration is based on an enantiomerically enriched 
sample of 12114.                                                                
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5 Experimental Part 
 
5.1 General 
 
5.1.1 Working conditions 
 
Bought chemicals were used without purification, liquids were distilled before use. The 
following reactions were carried out under nitrogen atmosphere, except the 
saponification of the malonates. The drying and nitrogen saturation of the solvents was 
carried out in circulation distils with the following dessicants: 
 
 Dichloromethane: P2O5 
 Ethanol: Mg  
 Tetrahydrofuran: Na/K alloy 
 Toluene: Na  
 Triethylamine: CaH2 
 
For chromatography silica gel was used (ordinary: Merck 60, mesh 0.063–0.200 mm; 
flash: Merck 9385, 230–400 mesh), TLC monitoring was performed with aluminium 
plates from Merck with fluorescent indicator (SiO2 60 F254, thickness of layer 0.2 mm). 
 
Bulb-to-bulb distillations were carried out with a distillation apparatus type GKR-50 
from Büchi company. 
 
Vacuum designations correspond to following pressures: 
Oil pump vacuum (OV): 1–2 Torr 
High vacuum (HV):  <10-3 Torr 
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5.1.2 Analytics 
 
Melting points 
Büchi SMP 20 
The melting points given are uncorrected. 
 
IR spectra 
Beckman Acculab 3 
The intensities are given in the following way: s = strong, m = middle, w = weak, br = 
broad.  
 
NMR spectroscopy 
Bruker AC 250 (250 MHz), Avance 300 (300 MHz), Avance 400 (400 MHz) and 
Avance 600 (600 MHz).  
The spectra were measured in deuterated solvents from Deutero company. The chemical 
shifts δ were given in ppm with tetramethylsilane as external standard. Coupling 
constants were indicated in Hz. Multiplicities were abbreviated as follows: s = singlet,   
d = doublet, t = triplet, q = quartet, m = multiplet, br = broad. All spectra were analyzed 
according to first order. 
 
Mass spectra 
EI MS: Finnigan MAT 311 A, CI and FD MS: Finnigan MAT 95, GC CI MS: JOEL D-
300. 
The intensities are relative to the most intense signal. Only the most intense peak of a 
cluster is given. 
 
Optical rotary power 
Perkin Elmer Polarimeter 241 
Measured at room temp. with a 1 dm cell. 
 
Elemental analysis 
Elementar Vario EL III 
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Gas chromatography 
Hewlett Packard HP 5890 and Thermoquest 8130-10, integrator: Spectra Physics SP 
4270. Injection amount 0.1 µL of a sample with a concentration of about 5 mg/mL in 
CH2Cl2. Precise conditions for the catalytic systems leading to amino acid derivatives 
are given in chapter 5.5.1.2. 
 
HPLC 
Apparatus: Hewlett Packard HP1090M, column thermostat: Agilent 1100 series, diode 
array detector measuring at 210 and 254 nm, column: Daicel OD-H (length 250 mm, 5 
µm inner diameter), solvent mixture: hexane:isopropanol 97:3 
Injection of 5 µL (3 mg/mL) at a flow of 0.6 mL/min resulting in a system pressure of 
about 45 bar. The retention times for the detected compounds are given in chapter 5.5.2. 
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5.2 Substrates for the α-amino acid system 
 
 
5.2.1 Preparation of 2-N-acetylamino-2-ethoxycarbonylpropionic  
         acid (1) 
 
5.2.1.1 Diethyl 2-N-acetylamino-2-methylmalonate (14)55 
 
Diethyl N-acetylaminomalonate (13) was added to a NaOEt solution (Na: 6.33 g, 275 
mmol; 275 mL EtOH). After dissolution of 13, methyl iodide (20.6 mL, 340 mmol) was 
added and the reaction mixture was refluxed for 20 h. The solvent was removed and the 
residue was dissolved in hot water. After cooling down, the formed crystals were 
collected and recrystallized from EtOH:PE (1:1). 
 
C10H17NO5 (231.3) 
Yield:        43.9 g (190 mmol, 76%),  
                   colorless solid 
Mp:         87–89 °C (lit. 88–90 °C) 
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 1.25 (t, 3J = 7.1 Hz, 6 H, CH2CH3), 1.75 (s, 3 
H, CH3), 2.02 (s, 3 H, COCH3), 4.23 (q, 3J = 7.1 Hz, 4 H, CH2CH3), 6.82 (s, 1 H, NH) 
 
 
 
5.2.1.2 2-N-Acetylamino-2-ethoxycarbonylpropionic acid (1)58  
 
To diethyl 2-N-acetylamino-2-methylmalonate (14) (10.0 g, 43.2 mmol) in ethanol (30 
mL), an aqueous solution of KOH (2.92 g, 43.2 mmol in 2.6 mL water) was added 
dropwise. After stirring the reaction mixture for 5 d at room temp., the solvents were 
removed in vacuo. The aqueous solution of the residue was washed 3 × with EtOAc to 
remove the starting material from the product. The water phase was acidified with 2 N 
HCl at 0 °C. The precipitating product was extracted 3 × with EtOAc. The organic 
layers were dried over Na2SO4. After removal of the solvents, the crude product was 
recrystallised from EtOAc:hexane (2:1). 
 
COOEt
NH
OEtO
O
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C8H13NO5 (203.2) 
Yield:       5.10 g (25.3 mmol, 58%),  
                  colorless solid 
Mp:        142–143 °C (lit. 135–136 °C), (dec., –CO2) 
 
IR (KBr): ν [cm-1] = 3320m (N–H); 2990w, 2940w (C–H); 2800–2200br (COOH); 
1730s (C=O); 1600s (amide I); 1540s (amide II); 1450m, 1380w (C–H)                       
 
1H NMR (250 MHz, [D6]DMSO): δ [ppm] = 1.13 (t, 3J = 7.0 Hz, 3 H, CH2CH3), 1.53 
(s, 3 H, CH3), 1.86 (s, 3 H, COCH3), 4.08 (q, 3J = 7.0 Hz, 2 H, CH2CH3), 8.15 (s, 1 H, 
NH), 13.46 (br s, 1 H, COOH) 
 
MS (CI, NH3): m/z (%) = 160.2 (92) [MH – CO2], 177.2 (100) [M + NH4 – COOH]  
 
Elemental analysis:  calcd.:  C  47.29 H  6.45 N  6.89 
    found:  C  47.34 H  6.49 N  6.82 
 
5.2.2 Preparation of 2-N-acetylamino-2-ethoxycarbonyl- 
         3-methylbutyric acid (2)  
 
5.2.2.1 Diethyl 2-N-acetylamino-2-isopropylmalonate (15)56 
 
Diethyl N-acetylaminomalonate (13) (15.0 g, 69.1 mmol) was added to a NaOEt 
solution (NaOEt: 5.17 g, 76.0 mmol; 125 mL EtOH). After dissolution of 13, isopropyl 
iodide (6.9 mL, 69.1 mmol) was added and the reaction mixture was refluxed for 48 h. 
After removal of the solvent, the residue was dissolved in hot water. After cooling 
down, the formed crystals were collected and washed with PE. 
 
C12H21NO5 (259.3) 
Yield:         3.62 g (14.0 mmol, 20%),  
                    colorless solid 
Mp:          71–72 °C (lit. 73 °C) 
 
 
COOEt
NH
OEtO
O
COOH
NH
OEtO
O  
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1H NMR (250 MHz, CDCl3): δ [ppm] = 0.93 (d, 3J = 6.9 Hz, 6 H, CH(CH3)2), 1.25 (t, 
3J = 7.1 Hz, 6 H, CH2CH3), 3.55 (s, 3 H, COCH3), 2.75 (sept, 3J = 6.9 Hz, 1 H, 
CH(CH3)2), 4.23 (q, 3J = 7.1 Hz, 4 H, CH2CH3), 6.54 (s, 1 H, NH) 
 
5.2.2.2 2-N-Acetylamino-2-ethoxycarbonyl-3-methylbutyric acid (2) 
 
Diethyl 2-N-acetylamino-2-isopropyl-malonate (15) (4.96 g, 19.1 mmol) was dissolved 
in EtOH (10 mL). A solution of KOH (1.28 g, 19.4 mmol) in water (1.3 mL) and EtOH 
(5.2 mL) was added dropwise. After stirring for 48 h, the solvents were removed in 
vacuo at room temp. The aqueous solution of the residue was washed 3 × with EtOAc to 
remove the starting material from the product. The water phase was acidified with half-
concentrated HCl at 0 °C. The precipitating product was extracted 3 × with EtOAc. The 
organic layers were dried over Na2SO4 adding charcoal to remove a pink color. 
Evaporation of the organic solvent yielded 2 as a colorless solid. 
 
C10H17NO5 (231.3) 
Yield:        1.50 g (6.49 mmol, 34%),  
                   colorless solid 
Mp:         130–132 °C (dec., –CO2) 
 
IR (KBr): ν [cm-1] = 3360s (N–H), 2980w, 2950w, 2890w (C–H); 2700–2180br 
(COOH); 1780s, 1720s (C=O); 1615s (amide I), 1550s (amide II); 1470w, 1450w, 
1420w (C–H) 
 
1H NMR (250 MHz, [D6]DMSO): δ [ppm] = 0.84, 0.87 (2 d, 3J = 6.9 Hz, 6 H, 
CH(CH3)2), 1.11 (t, 3J = 7.1 Hz, 3 H, CH2CH3), 1.89 (s, 3 H, COCH3), 2.40–2.57 (m, 1 
H, CH(CH3)2), 3.93–4.17 (m, 2 H, CH2CH3), 7.94 (s, 1 H, NH), 13.27 (br s, 1 H, 
COOH) 
 
MS (CI, NH3): m/z (%) = 142.0 (7) [M – COOH – EtOH], 188.1 (100) [M – COOH], 
205.1 (41) [M + NH4 – COOH] 
 
Elemental analysis:  calcd.:  C  51.94 H  7.41 N  6.06 
    found:  C  52.10 H  7.25 N  6.20 
 
COOH
NH
OEtO
O
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5.2.3 Preparation of 2-N-acetylamino-2-ethoxycarbonyl-3-phenyl- 
         propionic acid (3)  
  
5.2.3.1 Diethyl 2-N-acetylamino-2-benzylmalonate (16)57 
 
Diethyl acetylaminomalonate (13) (21.8 g, 100 mmol) was added to a NaOEt solution 
(NaOEt: 7.52 g, 110 mmol; 200 mL EtOH). After dissolution of 13, benzyl chloride 
(11.6 mL, 100 mmol) was added and the reaction mixture was refluxed for 10 h. After 
removal of the solvent, the residue was dissolved in hot Et2O and precipitated with PE 
(–30 °C). 
 
C16H21NO5 (307.3) 
Yield:         12.9 g (42.0 mmol, 42%),  
                    colorless solid  
Mp:          103–105 °C (lit. 104–106 °C)  
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 1.30 (t, 3J = 7.1 Hz, 6 H, CH2CH3), 2.03 (s, 3 
H, COCH3), 3.65 (s, 2 H, benzyl H), 4.27 (q, 3J = 7.1 Hz, 4 H, CH2CH3), 6.52 (br s, 1 
H, NH), 6.95–7.06 (m, 1 H, Ph), 7.20–7.28 (m, 4 H, Ph) 
 
5.2.3.2 2-N-Acetylamino-2-ethoxycarbonyl-3-phenylpropionic acid (3)59 
 
To a cooled (0 °C) suspension of diethyl 2-N-acetylamino-2-benzylmalonate (16) (12.5 
g, 40.7 mmol) in EtOH (60 mL) an aqueous KOH solution (2.69 g, 40.7 mmol in 15 mL 
water) was added dropwise. After 2 d stirring, the solvents were removed in vacuo and 
the residue was taken up in EtOAc/H2O. The aqueous phase was extracted 3 × with 
EtOAc in order to remove starting material. Then it was acidified at 0 °C with half-
concentrated HCl. The precipitating product was extracted 3 × with EtOAc, the organic 
layers dried over Na2SO4 and the solvent was evaporated. After dissolving the crude 
product in hot CDCl3, it was precipitated with PE (–30 °C). 
COOEt
NH
OEtO
O
Ph
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C14H17NO5 (279.3) 
Yield:         4.40 g (15.8 mmol, 39%),  
                    colorless solid 
Mp:          148–150 °C (lit. 129–130 °C), (dec., –CO2) 
  
IR (KBr):  ν [cm-1] = 3340s (N–H); 3020w, 2980w, 2940w (C–H); 2940–2100br 
(COOH); 1730s (C=O); 1610s (amide I); 1530s (amide II); 1450w, 1380w (C-H) 
 
1H NMR (250 MHz, [D6]DMSO): δ [ppm] = 1.15 (t, 3J = 7.1 Hz, 3 H, CH2CH3), 1.92 
(s, 3 H, COCH3), 3.37, 3.46 (2 d, 2J = 13.6 Hz, 2 H, benzyl H), 4.11 (q, 3J = 7.1 Hz, 2 
H, CH2CH3), 6.94–7.03 (m, 2 H, Ph), 7.17–7.30 (m, 3 H, Ph), 7.83 (br s, 1 H, NH), 
13.76 (br s, 1 H, COOH) 
 
MS (CI, NH3): m/z (%) = 188.1 (28) [M – COOH – EtOH], 206.2 (21) [M – COOH – 
C2H4], 234.2 (100) [M – COOH]  
 
Elemental analysis:  calcd.:  C  60.21 H  6.14 N  5.02 
    found:  C  59.61 H  6.03 N  4.92 
 
COOH
NH
OEtO
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5.3 Substrates for the α-fluoro ketone system 
 
 
5.3.1 Benzyl 2-fluoro-3-oxo-2,3-diphenylpropionate (7) 
 
5.3.1.1 Benzyl phenylacetate (18)30  
 
Phenylacetic acid (19.9 g, 146 mmol), benzyl bromide (27.5 g, 161 mmol) and K2CO3 
(24.2 g, 175 mmol) were refluxed in acetone (300 mL) for 11 h. The cold reaction 
mixture was filtered in order to remove the K2CO3. Water was added and after 3 × 
extraction with Et2O, the combined organic layers were washed with saturated NaCl 
solution. After drying over MgSO4 and evaporation, the crude product was flash 
chromatographed on SiO2  (PE:EtOAc 95:5). 
 
C15H14O2 (226.3) 
Yield:      22.3 g (98.6 mmol, 68%),  
                 colorless liquid 
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 3.70 (s, 2 H, PhCH2CO), 5.14 (s, 2 H; 
PhCH2OCO), 7.28–7.50 (m, 10 H, Ph) 
 
5.3.1.2 Benzyl 3-oxo-2,3-diphenylpropionate (19)30 
 
To HMDS (5.1 mL, 24 mmol) diluted with THF (15 mL), BuLi (1.6 M solution, 15 mL, 
24 mmol) was added dropwise at –78 °C. The mixture was stirred for 45 minutes at this 
temperature, then benzyl phenylacetate (18) (3.40 g, 15 mmol) in THF (15 mL) was 
added dropwise. After 15 min, the cooling was removed and the batch was stirred for 2 
h at room temp. Benzoyl chloride (2.3 mL; 18 mmol) was added dropwise at –78 °C 
and the mixture was stirred for 2 h. The reaction mixture was poured into 2 M HCl 
(containing ice-pieces) and extracted 3 × with Et2O. The organic layers were washed 
with saturated NaCl solution, dried over MgSO4, filtered and evaporated. The crude 
product was chromatographed on SiO2 (PE:EtOAc 95:5). The orange oil was taken up 
in Et2O, precipitated with PE and stored at –30 °C. 
 
 
O
O
Experimental Part 
 
 
58
C22H18O3 (330.4) 
Yield:      2.20 g (6.66 mmol, 44%),  
                 colorless solid 
Mp:       64–67 °C (Lit. 63 °C) 
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 5.13 (s, 2 H, benzyl H), 5.58 (s, 1 H, Ph), 7.15–
7.38 (m, 11 H, Ph), 7.39–7.49 (m, 1 H, Ph), 7.81–7.90 (m, 2 H, Ph) 
 
5.3.1.3 Benzyl 2-fluoro-3-oxo-2,3-diphenylpropionate (7) 
 
To a suspension of NaH (60% in mineral oil; 120 mg; 3.00 mmol) in THF (10 mL), 
benzyl 3-oxo-2,3-diphenyl-propionate (19) (990 mg, 3.00 mmol) in THF (20 mL) was 
added slowly at 0 °C. The mixture was stirred for 0.5 h at 0 °C and then 1 h at room 
temp. It was diluted with DMF (30 mL) and SelectfluorTM (1.06 g, 3.00 mmol) was 
added in one portion. The reaction mixture was stirred overnight at room temp. After 
addition of water it was extracted 3 × with Et2O, dried over MgSO4 and evaporated. The 
crude product was flash chromatographed on SiO2 (PE:EtOAc 95:5) and also on 
ordinary SiO2 (CH2Cl2). However, a trace of the byproduct fluorinated at the benzyl 
position (about 3%) could not be removed.  
 
C22H17FO3 (348.4) 
Yield:        570 mg (1.64 mmol, 55%),  
                   colorless oil 
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 5.33, 5.38 (2 d, 2J = 10.0 Hz, 1 H, benzyl H), 
7.28–7.67 (m, 13 H, Ph), 7.92–7.99 (m, 2 H, Ph) 
byproduct: δ [ppm] = 5.85 (d, 2JH,F = 48 Hz, 0.03 H, benzyl F) 
 
13C DEPT135 NMR (CDCl3, 62.9 MHz): δ [ppm] = 68.7 (s, CH2), 126.1 (d, J = 8.8 
ppm Hz, CH), 128.6 (s, CH), 129.0 (s, CH), 129.8 (s, CH), 130.6 (d, J = 5.0 Hz, CH), 
134.3 (s, CH)  
 
19F NMR (235 MHz, CDCl3): δ [ppm] = – 157.2 (s)  
byproduct: δ [ppm] = –179.87 (d, 2JH,F = 47 Hz, benzyl F) 
O
O
PhPh
O
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O
O
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GC–MS (CI, NH3): 6.82 min, m/z (%) = 244 (36) [M – PhCO], 262 (100) [M – PhCO + 
NH4]; byproduct: 7.07 min, m/z (%) = 134 (22) [PhCH2COO], 220 (11) 
[PhCOCHPhCOO], 268 (100) 
 
5.3.2 Benzyl 2-fluorocyclohexanone-2-carboxylate (9) 
 
5.3.2.1 Ethyl cyclohexanone-2-carboxylate (21)60 
 
Cyclohexanone (35.9 mL, 338 mmol) in THF (60 mL) was added to a suspension of 
NaH (16.6 g, 690 mmol) in THF (300 mL). After stirring for 45 min at room temp., 
diethyl carbonate (209 mL, 1.73 mol) was added dropwise. The reaction mixture was 
stirred for 1 h at room temp., then refluxed for 4 h at 70 °C. The cold batch was 
hydrolysed with 3 M acetic acid (350 mL) and extracted three times with Et2O. The 
combined organic layers were washed with NaHCO3 and saturated NaCl solution and 
dried over MgSO4. After removal of the solvent, purification was performed by 
fractionated destillation, first removing the lower boiling diethyl carbonate at 25 – 60 
°C (2 Torr). 
 
C9H14O3 (170.2) 
Yield:    19.7 g (116 mmol, 52%),  
               colorless liquid 
Bp:     70–80 °C (1 Torr)  
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 1.28, 1.29 (t enol, t ketone , 3J = 7.1 Hz, 3 H, 
CH2CH3), 1.49–2.01 (m, 4 H, CH2), 2.06–2.54 (m, 4 H, CH2), 3.26–3.50 (m, 0.2 H, H 
ketone), 4.19, 4.20 (q enol, q ketone, 3J = 7.1 Hz, 2 H, CH2CH3), 12.19 (s, 0.8 H, OH 
enol) 
 
5.3.2.2 Benzyl cyclohexanone-2-carboxylate (22)  
 
A mixture of ethyl cyclohexanone-2-carboxylate (21) (15.0 g, 88.1 mmol), benzyl 
alcohol (45.8 mL, 441 mmol) and toluene (500 mL) was stirred for 9 d at 120 °C.  
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Ethanol and toluene were removed at 150 °C without vacuum, then the benzyl alcohol 
at 130 °C (1 Torr). The product was purified by distillation in high vacuum (3 · 10-2 
Torr). 
 
C14H16O3 (232.3) 
Yield:      12.8 g (55.1 mmol, 63%),  
                 colorless liquid 
Bp:       100–110 °C (3 · 10-2 Torr)  
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 1.47–2.00 (m, 4 H, CH2), 2.10–2.59 (m, 4 H, 
CH2), 3.39–3.49 (m, 0.2 H, H ketone), 5.17, 5.26 (2 d, 2J = 12.5 Hz, 2 H, benzyl H), 
7.27–7.48 (m, 5 H, Ph), 12.16 (s, 0.8 H, OH enol) 
 
5.3.2.3 Benzyl 2-fluorocyclohexanone-2-carboxylate (9)  
 
To benzyl cyclohexanone-2-carboxylate (22) (1.50 g, 6.46 mmol) in acetonitrile (65 
mL), SelectfluorTM (2.29 g, 6.46 mmol) was added in one portion and the reaction 
mixture was stirred for 20 h. After removal of the solvent, the residue was taken up in 
CH2Cl2/H2O and extracted 3 × with CH2Cl2. The organic layer was washed with water 
and dried over MgSO4, filtered and evaporated. The crude product was 
chromatographed on SiO2 (PE:EtOAc 90:10).  
 
C14H15FO3 (250.3) 
Yield:        1.30 g (5.19 mmol, 80%),  
                   colorless liquid  
 
IR (neat):  ν [cm-1] = 3080w, 3060w, 2980m, 2890w (C–H); 1790s, 1760s (C=O); 
1540w, 1490m (C=C); 1370w, 1420w (C–H) 
 
1H NMR (300 MHz, CDCl3): δ [ppm] = 1.74–1.98 (m, 4 H, CH2), 2.08–2.24 (m, 1 H, 
CH2), 2.36–2.63 (m, 2 H, CH2), 2.65–2.79 (m, 1 H, CH2), 5.24, 5.29 (d, 2J = 12.1 Hz, 2 
H, benzyl H), 7.30–7.42 (m, 5H, Ph) 
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13C NMR (75.5 MHz, CDCl3): δ [ppm] = 20.8 (d, J = 5.2 Hz), 26.6 (s), 36.0 (d, J = 21.4 
Hz), 39.6 (s), 67.8 (s), 96.4 (d, J = 196.8 Hz, CF), 128.3 (s), 128.6 (s), 128.7 (s), 134.8 
(s), 166.8 (d, J = 25.1 Hz, C=O ester), 201.8 (d, J = 19.9 Hz, C=O oxo)  
 
19F NMR (235 MHz, CDCl3): δ [ppm] = 160.97 (ddd, 3JH,F (aa)  = 21.9, 3JH,F (ae) = 13.7, 
4J = 5.1 Hz)  
 
GC–MS (CI, NH3): m/z (%) = 108 (29) [PhCH2OH], 134 (5) [C6H9FO + NH4], 250 (4) 
[M], 268 (100) [M + NH4] 
 
 
5.3.3 Benzyl 2-fluoro-1-tetralone-2-carboxylate (11) 
 
5.3.3.1 Ethyl 1-tetralone-2-carboxylate (24)23  
 
To a suspension of NaH (5.23 g, 218 mmol) in toluene (70 mL), diethyl carbonate (73 
mL, 602 mmol) was added. A solution of 1-tetralone (16.0 g, 111 mmol) in toluene (250 
mL) was added dropwise. The reaction mixture was stirred for 2 h at room temp. 
Refluxing the brown suspension for 10 h afforded a yellow/brown solid which was 
dissolved in ice water containing ethanol (10 mL). After dropwise acidification with 2 
M HCl, the aqueous phase was extracted 3 × with Et2O. The combined organic layers 
were dried over MgSO4 and the solvents and diethyl carbonate were evaporated. The 
crude product was purified by distillation (1 · 10-3 Torr, T = 200 °C).   
 
C18H16O3 (218.3) 
Yield:      16.1 g (73.8 mmol, 67%),  
                 yellow liquid 
Bp:       200 °C (1 · 10-3 Torr)  
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 1.32 (t ketone, t enol, 3J = 7.2 Hz, 3 H, 
CH2CH3), 2.25–2.40 (m, 0.6 H, CH2 ketone), 2.49–2.63 (m, 1.4 H, CH2 enol), 2.72–
2.87 (m, 1.4 H, CH2 enol), 2.95–3.10 (m, 0.6 H, CH2 ketone), 3.60 (dd, 3J(aa) = 10.3 Hz, 
3J(ae) = 4.8 Hz, 0.3 H ketone), 4.25, 4.28 (q ketone, q enol, 3J = 7.2 Hz, 2 H, CH2CH3), 
7.12–7.20 (m, 0.7 H, CH2 enol), 7.20–7.39 (m, 2 H, Ph), 7.49 (td, 3J = 7.4 Hz, 4J = 1.4 
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Hz, 0.3 H, Ph ketone), 7.80 (dd, 3J = 7.1 Hz, 4J = 1.7 Hz, 0.7 H, Ph enol), 8.00 (dd, 3J = 
8.1 Hz, 4J = 0.8 Hz, 0.3 H, Ph ketone), 12.2 (s, 0.7 H, OH enol) 
 
 
5.3.3.2 Benzyl 1-tetralone-2-carboxylate (25) 
 
Ethyl 1-tetralone-2-carboxylate (24) (10.5 g, 48.1 mmol), benzyl alcohol (25 mL, 241 
mmol) and toluene (250 mL) were stirred at 120 °C for 6 d. Toluene was removed at 
150 °C. Afterwards the benzyl alcohol was distilled off at 150 °C (1 Torr). Purification 
with bulb-to-bulb distillation (170–210 °C, 1 · 10-4 Torr). 
 
C18H16O3 (280.3) 
Yield:      8 g (28.5 mmol, 59%),  
                 yellow liquid  
Bp:       170–210 °C (1 · 10-4 Torr)  
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 2.32–2.73 (m, 2 H, CH2), 2.78–2.87 (m, 1 H, 
CH2), 2.95–3.10 (m, 1 H, CH2), 3.70 (dd, 3J(aa) = 10.4 Hz, 3J(ae) = 4.7 Hz, 0.4 H, H 
ketone), 5.17, 5.26 (2 d, 2J = 12.2 Hz, 2 H, benzyl H), ), 7.12–7.54 (m, 8 H, Ph), 7.85 
(dd, J = 7.3 Hz, J = 1.5 Hz, 0.6 H, Ph enol), 8.10 (d, J = 7.9 Hz, 0.4 H, Ph ketone), 
12.45 (s, 0.6H, OH enol) 
 
5.3.3.3 Benzyl 2-fluoro-1-tetralone-2-carboxylate (11) 
 
To benzyl 1-tetralone-2-carboxylate (25) (2.34 g, 8.35 mmol) in acetonitrile (100 mL), 
SelectfluorTM (2.96 g, 8.35 mmol) was added in one portion. The reaction mixture was 
stirred for 19 h at room temp. After evaporation of the solvent, the remaining residue 
was taken up in H2O/CH2Cl2 and extracted 3 × with CH2Cl2. The combined organic 
layers were dried over MgSO4 and evaporated. Chromatography on SiO2 (PE:EtOAc 
90:10) afforded an orange oil. Recrystallisation from Et2O gave a colorless solid.  
 
C18H15FO3 (298.3) 
Yield:        1.72 g (5.77 mmol, 69%),  
                   colorless needles  
Mp:         64–65 °C  
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IR (KBr):  ν [cm-1] = 3500w, 3370w; 3060w, 3030w, 2940w, 2890w (C–H); 1760s, 
1700s (C=O); 1600m, 1500w (C=C); 1490w, 1460m, 1430w (C–H) 
 
1H NMR (300 MHz, CDCl3): δ [ppm] = 2.55 (dddd, 3J = 13.8 Hz, 3J = 11.3 Hz, 3J = 8.0 
Hz, 4J = 5.2 Hz, 1 H, CH2), 2.72 (dddd, 3J = 13.8 Hz, 3J = 11.3 Hz, 3J = 8.0 Hz, 4J = 5.2 
Hz, 1 H, CH2), 3.00 (ddd, 3JH,F(aa) = 17.2 Hz, 3JH,F(ae) = 7.8 Hz, 3J = 5.0 Hz, 1 H, CH2), 
3.17 (td, 3JH,F(aa) = 17.3 Hz, 3J = 6.2 Hz, 1 H, CH2), 5.22, 5.30 (2 d, 2J = 12.3 Hz, 2 H, 
benzyl H), 7.22–7.33 (m, 6 H, Ph), 7.37 (t, 3J = 8.1 Hz, 2 H, Ph), 7.55 (td, 3J = 7.5 Hz, 
4J = 1.4 Hz, 1 H, Ph), 8.08 (dd, 3J = 7.8 Hz, 4J = 1.2 Hz, 1 H, Ph) 
 
13C NMR (75.5 MHz, CDCl3): δ [ppm] = 24.8 (d, J = 7.3 Hz, CH2); 31.9 (d, J = 22.1 
Hz, CH2), 67.7 (s, CH2), 93.3 (d, J = 193.9 Hz, CF), 127.3 (s, CH), 128.0 (s, CH), 128.5 
(d, J = 2.9 Hz, CH), 128.6 (s, CH), 128.8 (s, CH), 134.6 (s, CH), 132.7 (d, J = 193.9 Hz, 
C quart.), 143.1 (s,  2 C quart.), 167.2 (d, J = 26.5 Hz, C=O ester), 188.5 (d, J = 19.2 
Hz, C=O oxo) 
 
19F NMR (235 MHz, CDCl3): δ = – 164.94 (dd, 3JH,F (aa) = 22.4 Hz, 3JH,F (ae)  = 10.3 Hz) 
 
MS (EI, 70 eV): m/z (%) = 91 (100) [PhCH2], 164 (43) [C10H9FO], 298.1 (27) [M] 
 
Elemental analysis:  calcd.:  C  72.47 H  5.07 
    found:  C  72.21 H  4.84 
 
 
5.3.4 2-Fluoro-1-tetralol (27) 
 
To NaBH4 (32.0 mg, 0.85 mmol) in isopropanol (10 mL), 2-fluoro-1-tetralone115 (12) 
(320 mg, 1.95 mmol) in isopropanol (10 mL) was added dropwise at room temp. After 
stirring overnight, the reaction mixture was cooled and diluted HCl was added dropwise 
until no more hydrogen developed. The solvents were removed, the residue was taken 
up in H2O/CH2Cl2 and extracted with CH2Cl2 (3 × 25 mL). After removal of the 
solvents, the residue was chromatographed on SiO2 (CH2Cl2), yielding a colorless oil 
(170 mg, 1.02 mmol).  
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C10H11FO (166.2) 
Yield:       170 mg (1.02 mmol, 53%),  
                  Colorless oil  
 
 
1H NMR (600 MHz, CDCl3): δ [ppm] = 1.98–2.13 (m, 1 H, CH2), 2.22–2.31 (m, 0.3 H, 
CH2), 2.36–2.50 (m, 1.3 H, CH2, OH), 2.79–2.85 (m, 0.7 H, CH2), 2.88–3.01 (m, 0.7 H, 
CH2), 3.02–3.10 (m, 1 H, CH2), 4.79 (ddddd, 2JH,F = 50.2 Hz, 3J(aa/ee) = 9.7 Hz, 3J(aa/ee) = 
6.7 Hz, 4J = 3.5 Hz, 5J = 0.4 Hz, 0.3 H, trans-isomer), 4.80–4.89 (m, 1H, CH), 5.01 
(ddddd, 2JH,F = 49.7 Hz, 3J(aa/ee) = 8.6 Hz, 3J(ae) = 3.4 Hz, 4J = 2.7 Hz, 5J = 0.4, 0.7 H,  
FCH cis-isomer), 7.12–7.17 (m, 1 H, Ph), 7.23–7.30 (m, 2 H, Ph), 7.52–7.55 (m, 0.7 H, 
Ph, cis-isomer), 7.55–7.58 (m, 0.3 H, Ph, trans-isomer) 
 
MS (EI, 70 eV): m/z (%) = 91 (36), 119 (100), 148 (70) [M – H2O], 166 (42) [M]  
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5.4 Synthesis of the catalysts 
 
 
5.4.1 9-Amino(9-deoxy)epicinchonine (29)51  
 
To a cooled (0 °C) suspension of cinchonine (25.0 g, 84.9 mmol) in THF (400 mL), 106 
mL of a benzene solution of HN3116 (102 mmol, c = 0.96 mol/l) and PPh3 (26.8 g, 102 
mmol) were added. After stirring for 5 min, diisopropylazodicarboxylate (18.3 mL, 93.4 
mmol) in THF (80 mL) was added dropwise. After strirring 3 h at room temp., PPh3 
(22.3 g, 84.8 mmol) in THF (80 mL) was added and the reaction mixture was heated to 
40 °C and stirred for another 3 h at this temperature. Then water (8.5 mL) was added 
and stirring was continued for further 3 h. The solvents were removed in vacuo and the 
residue was dissolved in 2 M HCl (400 mL). The aqueous phase was extracted 3 × with 
CH2Cl2. After removal of the solvents the crude hydrochloride was recrystallized from 
methanol. The hydrochloride (20.5 g, 50.8 mmol, 60%) was dissolved in water, 
neutralized with saturated Na2CO3 and extracted 3 × with CH2Cl2 to liberate the free 
base. After drying the organic layers over Na2CO3 and removal of the solvent, the 
yellow oil was purified by bulb-to-bulb distillation (220 °C/ 0.01 Torr).  
 
C19H23N3 (293.4) 
Yield:      10.4 g (35.4 mmol, 42%),  
                 yellow oil 
Bp:       220 °C (0.01 Torr) 
 
IR (neat): ν [cm-1] = 3380m, 3300w (N–H); 3080m, 3040w, 2940s, 2860s (C–H); 
1640m, 1590s, 1570s, 1510s (C=C) 
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 0.85–1.00 (m, 1 H, H7b), 1.08–1.25 (m, 1 H, 
H7a), 1.51–1.60 (m, 3 H, H4, H5), 1.97 (s, 2 H, NH2), 2.28 (m, 1 H, H3), 2.89–3.09 (m, 
5 H, H2, H6, H8), 4.77 (d, 3J  = 9.9 Hz, 1 H, H9), 5.03–5.11 (m, 2 H, H11a, H11b), 5.87 
(ddd, 3J = 16.3 Hz, 3J = 11.5 Hz, 3J = 6.7 Hz, 1 H, H10), 7.56–7.63 (m, 2 H, H3’, H7’), 
7.68–7.76 (m, 1 H, H6’), 8.14 (d, 3J´ = 8.3 Hz, 1 H, H5’), 8.36 (d, 3J = 8.3 Hz, 1 H, 
H8’), 8.90 (d, 3J = 4.4 Hz, 1 H, H2’) 
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MS (EI, 70 eV): m/z (%) = 81.9 (92) [quinuclidine – C4H7], 136 (100) [quinuclidine], 
293.3 (89) [M] 
 
Optical rotary power:  
D][α  = 132°, 578][α  = 139°, 546][α  = 160°, 436][α  = 293°  (c = 0.63, CHCl3) 
 
Elemental analysis:  calcd.:  C  77.78 H  7.90 N  14.32 
    found:  C  77.39 H  7.97 N  14.17 
 
 
 
5.4.2 General procedure for the synthesis of the amides of 9-amino(9- 
          deoxy)epicinchonine (29) 
 
 
29 was dissolved in the given amount of CH2Cl2 and NEt3. Then a solution of the 
appropriate benzoyl chloride in CH2Cl2 was added dropwise at 0 °C. After stirring for 
10 h at room temp., the reaction mixture was diluted with CH2Cl2 and washed 3 × with 
half-concentrated Na2CO3 solution, dried over Na2CO3 and evaporated. 
Amides 30, 32, 33, 35, 37, 38 were transformed into the hydrochloride before 
chromatography. This was done by stirring the crude product with an excess of 
ethanolic HCl for 10 h. After removal of the solvent, the hydrochloride was 
recrystallized or precipitated as described. The free base was liberated by dissolving the 
hydrochloride in water, adding an excess of saturated Na2CO3 solution and extraction 
with CH2Cl2.  
All the amides were purified by chromatography on silica gel with MeOH as eluent. As 
after evaporation of the chromatography fractions often foams resulted, recrystallisation 
was carried out in most cases. Further details are given for the individual compounds. 
Some amide derivatives included water affecting elemental analyses but showing up in 
the 1H NMR spectra. 
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5.4.2.1 N-(9-Deoxyepicinchonine-9-yl)benzamide (30)51  
 
 
29 (800 mg, 2.73 mmol), CH2Cl2 (20 mL), NEt3 (5.5 mL) and benzoyl chloride (507.5 
mg, 3.61 mmol), CH2Cl2 (5 mL). The hydrochloride was dissolved in MeOH, 
precipitated with acetone and stored at –30 °C.  
 
C26H27N3O (397.5) 
Yield:         280 mg (0.70 mmol, 26%),  
                    colorless solid 
Mp:          95–96 °C (lit. 93 °C) 
 
IR (KBr):  ν [cm-1] = 3480m, 3320m, 3200 (N–H); 3060m, 3950m, 2880m (C–H); 
1630s (amide I); 1580s, (C=C); 1540s (amide II) 
 
1H NMR (300 MHz, CDCl3): δ [ppm] = 0.97–1.12 (m, 1 H, H7b), 1.35–1.65 (m, 4 H, 
H4, H5, H7a), 2.27–2.43 (m, 1 H, H3), 2.85–3.29 (m, 5 H, H2, H6, H8), 5.15 (td, 3J = 
17.3 Hz, 2J = 1.4 Hz, 4J = 1.4 Hz, 1 H, H11b), 5.17 (td, 3J = 10.7 Hz, 2J = 1.4 Hz, 4J = 
1.4 Hz, 1 H, H11a), 5.48 (br s, 1 H, H9), 5.94 (ddd, 3J = 17.1 Hz, 3J = 10.6 Hz, 3J = 6.5 
Hz, 1 H, H10), 7.38–7.50 (m, 3 H, H3’’, H4’’), 7.53 (d, 3J = 4.7 Hz, 1 H, H3’), 7.57–
7.67 (m, 1 H, H6’), 7.68–7.78 (m, 1 H, H7’), 7.84 (dd, 3J = 8.1 Hz, 4J = 1.2 Hz, 2 H, 
H2’’), 8.03 (br s, 1 H, NH), 8.14 (dd, 3J = 8.5 Hz, 4J = 1.1 Hz, 1 H, H8’), 8.45 (d, 3J 
= 8.0 Hz, 1 H, H5’), 8.88 (d, 3J = 4.4 Hz, 1 H, H2’) 
 
MS (EI, 70eV): m/z (%) = 105 (100) [PhCO], 136.1 (76) [quinuclidine], 276.2 (73) [M 
– PhCO], 397.2 (44) [M]  
 
Optical rotary power:  
D][α  = 261°, 578][α  = 288°, 546][α  = 333°, 436][α  = 630° (c = 0.51, CHCl3) 
 
Elemental analysis:   
      calcd. for C26H27N3O · 0.5 H2O:         C  76.82 H  6.94  N  10.33 
    found:  C  76.27 H  6.89 N  10.20 
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5.4.2.2 N,N´-Bis(9-deoxyepicinchonine-9-yl)isophthalamide (31)51  
 
 
29 (1.62 g, 5.53 mmol), CH2Cl2 (25 mL), NEt3 (10 mL) and isophthalic acid chloride117 
(555.3 mg, 2.74 mmol), CH2Cl2 (5 mL). The crude product was taken up with CH2Cl2 
and precipitated with Et2O. 
 
C46H48N6O2 (716.9) 
Yield:          550 mg (0.77 mmol, 14%),  
                     colorless solid 
Mp:           216–218 °C (lit. 224 °C) 
 
IR (KBr):   ν [cm-1] = 3380m (N–H), 3080w, 2960s, 2880s (C–H), 1660s (amide I), 
1590m, 1570w (C=C), 1510s (amide II) 
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 0.83–1.08 (m, 2 H, H7b), 1.30–1.72 (m, 8 H, 
H4, H5, H7a), 2.22–2.39 (m, 2 H, H3), 2.73–3.19 (m, 10 H, H2, H6, H8), 5.11 (td, 3J = 
17.2 Hz, 2J = 1.5 Hz, 4J = 1.5 Hz, 2 H, H11b), 5.18 (td, 3J = 10.5 Hz, 2J = 1.4 Hz, 4J  = 
1.4 Hz, 2 H, H11a), 5.40 (br s, 2 H, H9), 5.93 (ddd, 3J = 17.2 Hz, 3J  = 10.5 Hz, 3J  = 6.4 
Hz, 2 H, H10), 7.45 (d, 3J = 4.8 Hz, 2 H, H3’), 7.51 (d, 3J  = 7.7 Hz, 1 H, H5’’), 7.55–
7.66 (m, 2 H, H6’), 7.67–7.78 (m, 2 H, H7’), 7.94 (dd, 3J = 7.7 Hz, 4J  = 1.7 Hz, 2 H, 
H4’’), 8.00 (br s, 2 H, NH), 8.14 (dd, 3J  = 8.4 Hz, 4J  = 1.2 Hz, 2 H, H8’), 8.31 (t, 4J = 
1.6 Hz, 1 H, H2’’), 8.41 (d, 3J = 8.2 Hz, 2 H, H5’), 8.85 (d, 3J = 4.5 Hz, 2 H, H2’) 
 
MS (PI-DCI, NH3): m/z (%) = 277.6 (100) [C19H21N2], 717.7 (14) [MH]  
 
Optical rotary power:  
D][α  = 254°, 578][α  = 265°, 546][α  = 318°, 436][α  = 602° (c = 0.92, CHCl3) 
 
Elemental analysis:   
     calcd. for C46H48N6O3 · 1.5 H2O:  C  74.27 H  6.91           N 11.30 
    found:  C  74.24          H  6.58           N 11.34 
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5.4.2.3  N-(9-Deoxyepicinchonine-9-yl)-2-methoxybenzamide (32)25  
 
 
29 (1.00 g, 3.41 mmol), CH2Cl2 (18 mL), NEt3 (7 mL) and 2-methoxybenzoyl 
chloride118 (1.00 g, 5.86 mmol), CH2Cl2 (4 mL). The hydrochloride was dissolved in 
MeOH, precipitated with acetone and stored at –30 °C.  
 
C27H29N3O2 (427.5) 
Yield:          420 mg (0.98 mmol, 29%),  
                     colorless solid 
Mp:           79–80 °C (lit. 83–84 °C) 
 
IR (KBr):    ν [cm-1] = 3380m (N–H), 3080w, 2940m, 2880w (C–H); 1660s (amide I); 
1600s (C=C); 1510s (amide II) 
 
1H NMR (300 MHz, CDCl3): δ [ppm] = 0.80–1.02 (m, 1 H, H7b), 1.21–1.62 (m, 4 H, 
H4, H5, H7a), 2.25–2.38 (m, 1 H, H3), 2.85–3.18 (m, 5 H, H2, H6, H8), 4.00 (s, 3 H, 
OCH3), 5.14 (td, 3J = 17.4 Hz, 2J = 1.5 Hz, 4J = 1.5 Hz, 1 H, H11b), 5.16 (td, 3J = 10.6 
Hz, 2J = 1.4 Hz, 4J = 1.4 Hz, 1 H, H11a), 5.48 (br d, 1 H, H9), 5.94 (ddd, 3J  = 17.2 Hz, 
3J = 10.6 Hz, 3J = 6.6 Hz, 1 H, H10), 6.94–7.02 (m, 2 H, H3’’, H5’’), 7.44–7.36 (m, 1 
H, H4’’), 7.48 (d, 3J = 4.6 Hz, 1 H, H3’), 7.54–7.64 (m, 1 H, H6’), 7.66–7.75 (m, 1 H, 
H7’), 7.99 (dd, 3J = 8.2 Hz, 4J = 1.9 Hz, 1 H, H6’’), 8.12 (dd, 3J = 8.5 Hz, 4J  = 1.1 Hz, 1 
H, H8’), 8.45 (dd, 3J = 8.6 Hz, 4J = 0.9 Hz, 1 H, H5’), 8.86 (d, 3J = 4.6 Hz, 1 H, H2’), 
9.33 (br s, 1 H, NH) 
 
MS (EI, 70eV): m/z (%) = 135.0 (100) [2-MeO-PhCO], 276.2 (41) [M – 2-MeO-
PhCONH], 292.1 (23) [M – quinuclidine], 427.3 (23) [M]   
 
Optical rotary power:  
D][α  = 312°, 578][α  = 320°, 546][α  = 378°, 436][α  = 741° (c = 0.47, CHCl3) 
 
Elemental analysis:   
     calcd. for C27H29N3O2 · 0.5 H2O:  C  74.29 H  6.93 N  9.63 
    found:  C  74.64 H  6.89 N  9.74 
N
N
HN
O
8
9
2'
3'
8'
7'
6'
5'
2
3
10
11a11b
4
7
5 6
5''
4''
3''
6''
O
Experimental Part 
 
 
70
5.4.2.4 N-(9-Deoxyepicinchonine-9-yl)-3-methoxybenzamide (33)25  
 
 
29 (1.00 g, 3.41 mmol), CH2Cl2 (18 mL), NEt3 (7 mL) and 3-methoxybenzoyl 
chloride118 (1.00 g, 5.86 mmol), CH2Cl2 (4 mL). The hydrochloride was dissolved in 
MeOH, precipitated with acetone and stored at –30 °C. The free base was crystallized 
from Et2O. 
 
C27H29N3O2 (427.5) 
Yield:          300 mg (0.70 mmol, 21%),  
                     colorless solid 
Mp:           80–82 °C (lit. 81–83 °C) 
 
IR (KBr):     ν [cm-1] = 3480m, 3340m, 3220 (N–H); 3100m, 3080m, 3940m, 2880m 
(C–H); 1640s (amide I); 1600s, 1580s, (C=C); 1530s (amide II) 
 
1H NMR (300 MHz, CDCl3): δ [ppm] = 0.95–1.11 (m, 1 H, H7b), 1.33–1.75 (m, 4 H, 
H4, H5, H7a), 2.26–2.42 (m, 1 H, H3), 2.81–3.29 (m, 5 H, H2, H6, H8), 3.80 (s, 3 H, 
OCH3), 5.14 (td, 3J = 17.2 Hz, 2J = 1.5 Hz, 4J = 1.5 Hz, 1 H, H11b), 5.20 (td, 3J = 10.9 
Hz, 2J = 1.5 Hz, 4J = 1.5 Hz, 1 H, H11a), 5.45 (br s, 1 H, H9), 5.94 (ddd, 3J = 17.1 Hz, 
3J = 10.6 Hz, 3J = 6.5 Hz, 1 H, H10), 6.99–7.07 (m, 1 H, H4’’), 7.30–7.43 (m, 3 H, 
H2’’, H5’’, H6’’), 7.52 (d, 3J = 4.8 Hz, 1 H, H3’), 7.57–7.66 (m, 1 H, H6’), 7.67–7.77 
(m, 1 H, H7’), 8.00 (br s, 1 H, NH), 8.13 (dd, 3J = 8.2 Hz, 4J = 1.1 Hz, 1 H, H8’), 8.44 
(dd, 3J = 8.6 Hz, 4J = 0.9 Hz, 1 H, H5’), 8.87 (d, 3J = 4.4 Hz, 1 H, H2’) 
 
MS (EI, 70eV): m/z (%) = 135.0 (100) [3-MeO-PhCO], 276.2 (76) [M – 3-MeO-
PhCONH], 292.1 (41) [M – quinuclidine], 427.3 (49) [M]   
   
Optical rotary power:  
D][α  = 273°, 578][α  = 281°, 546][α  = 325°, 436][α  = 620° (c = 0.53, CHCl3) 
 
Elemental analysis:   
        calcd. for C27H29N3O2 · 1 H2O:  C  72.78 H  7.01 N  9.43 
    found:  C  72.96 H  6.67 N  9.45 
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5.4.2.5 N-(9-Deoxyepicinchonine-9-yl)-4-methoxybenzamide (34)25  
 
 
29 (1.00 g, 3.41 mmol), CH2Cl2 (18 mL), NEt3 (7 mL) and 4-methoxybenzoyl chloride 
(1.00 g, 5.86 mmol), CH2Cl2 (4 mL). The free base was recrystallized from Et2O. 
 
C27H29N3O2 (427.5) 
Yield:          450 mg (1.05 mmol, 31%),  
                     colorless solid 
Mp:           138–140 °C (lit. 135–137 °C) 
 
IR (KBr):    ν [cm-1] = 3340m (N–H); 3080w, 2950s, 2880m (C–H); 1640s (amide I); 
1610s, 1580s, 1540s (C=C); 1510s (amide II) 
 
1H NMR (300 MHz, CDCl3): δ [ppm] = 0.91–1.06 (m, 1 H, H7b), 1.34–1.71 (m, 4 H, 
H4, H5, H7a), 2.24–2.37 (m, 1 H, H3), 2.77–3.16 (m, 5 H, H2, H6, H8), 3.83 (s, 3 H, 
OCH3), 5.12 (td, 3J = 17.2 Hz, 2J = 1.5 Hz, 4J = 1.5 Hz, 1 H, H11b), 5.17 (td, 3J = 10.5 
Hz, 2J = 1.4 Hz, 4J = 1.4 Hz, 1 H, H11a), 5.38 (br d, 1 H, H9), 5.93 (ddd, 3J = 17.2 Hz, 
2J = 10.6 Hz, 3J = 6.6 Hz, 1 H, H10), 6.91 (d, 3J = 8.8 Hz, 2 H, H3’’), 7.49 (d, 3J = 4.6 
Hz, 1 H, H3’), 7.56–7.63 (m, 1 H, H6’), 7.67–7.81 (m, 2 H, H7’, NH), 7.77 (d, 3J = 8.9 
Hz, 2 H, H2’’), 8.13 (dd, 3J = 8.4 Hz, 4J = 1.1 Hz, 1 H, H8’), 8.44 (dd, 3J = 8.6 Hz, 4J = 
0.9 Hz, 1 H, H5’), 8.86 (d, 3J = 4.5 Hz, 1 H, H2’) 
 
MS (EI, 70eV): m/z (%) = 135.0 (100) [4-MeO-PhCO], 276.2 (45) [M – 4-MeO-
PhCONH], 292.1 (22) [M – quinuclidine], 427.3 (23) [M]   
  
Optical rotary power:  
D][α  = 293°, 578][α  = 307°, 546][α  = 356°, 436][α  = 685°  (c = 0.51, CHCl3) 
 
Elemental analysis:   
      calcd. for C27H29N3O2 · 0.5 H2O:  C  74.29 H  6.93 N  9.63 
     found:  C  74.29 H  6.65 N  9.56 
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5.4.2.6 N-(9-Deoxyepicinchonine-9-yl)-3,5-di-tert-butylbenzamide (35)25  
 
 
29 (1.00 g, 3.41 mmol), CH2Cl2 (18 mL), NEt3 (7 mL) and 3,5-di-tert-butylbenzoyl 
chloride118 (1.07 g, 4.23 mmol), CH2Cl2 (4 mL). The hydrochloride was dissolved in 
MeOH, precipitated with Et2O and stored at –30 °C. The free base was recrystallized 
from Et2O. 
 
C34H43N3O (509.7) 
Yield:         520 mg (0.70 mmol, 30%),  
                    colorless solid 
Mp:          208–210 °C (lit. 209–210 °C) 
 
IR (KBr):   ν [cm-1] = 3380m (N–H); 3080w, 2960s, 2880m (C–H); 1650s (amide I), 
1590s, 1570w (C=C); 1510m (amide II) 
 
1H NMR (300 MHz, CDCl3): δ [ppm] = 0.94–1.09 (m, 1 H, H7b), 1.34 (s, 18 H, CH3), 
1.38–1.74 (m, 4 H, H4, H5, H7a), 2.27–2.40 (m, 1 H, H3), 2.79–3.20 (m, 5 H, H2, H6, 
H8), 5.13 (td, 3J = 17.3 Hz, 2J = 1.6 Hz, 4J = 1.6 Hz, 1 H, H11b), 5.19 (td, 3J = 10.6 Hz, 
2J = 1.4 Hz, 4J = 1.4 Hz, 1 H, H11a), 5.43 (br d, 1 H, H9), 5.95 (ddd, 3J = 17.2 Hz, 
3J = 10.6 Hz, 3J = 6.6 Hz, 1 H, H10), 7.54 (d, 3J = 4.4 Hz, 1 H, H3’), 7.57 (t, 3J = 1.8 
Hz, 1 H, H4’’), 7.58–7.64 (m, 1 H, H6’), 7.64 (d, 3J = 1.6 Hz, 2 H, H2’’), 7.68–7.77 (m, 
1 H, H7’), 7.89 (br s, 1 H, NH), 8.14 (dd, 3J = 8.5 Hz, 4J = 1.1 Hz, 1 H, H8’), 8.47 (d, 
3J = 8.2 Hz, 1 H, H5’), 8.88 (d, 3J = 4.7 Hz, 1 H, H2’) 
 
MS (PI-EI, 70 eV): m/z (%) = 217.1 (75) [3,5-di-tert-butyl-PhCO], 276.1 (100) [M – 
3,5-di-tert-butyl-PhCONH], 509 (40) [M]  
 
Optical rotary power:  
D][α  = 251°, 578][α  = 267°, 546][α  = 309°, 436][α  = 571° (c = 0.32, CHCl3)  
 
Elemental analysis:  calcd.:  C  80.12 H  8.50 N  8.24  
    found:  C  79.76 H  8.50 N  8.21 
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5.4.2.7 N-(9-Deoxyepicinchonine-9-yl)-3,5-difluorobenzamide (36) 
 
 
29 (848 mg, 2.89 mmol), CH2Cl2 (15 mL), NEt3, (6 mL) and 3,5-difluorobenzoyl 
chloride  (748 mg, 4.24 mmol), CH2Cl2 (4 mL). Recrystallization from Et2O.  
 
C26H25F2N3O (433.5) 
Yield:  326 mg (0.75 mmol, 26%),  
             colorless solid 
Mp:   134–137 °C  
 
IR (KBr):  ν [cm-1] = 3320m, 3230m (N–H); 3100m, 3060m, 2940s, 2880m (C–H); 
1640s (amide I); 1595s, 1545s (C=C); 1515s (amide II) 
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 0.95–1.09 (m, 1 H, H7b), 1.30–1.71 (m, 4 H, 
H4, H5, H7a), 2.25–2.41 (m, 1 H, H3), 2.89–3.18 (m, 5 H, H2, H6, H8), 5.12 (td, 3J = 
17.6 Hz, 2J = 1.7 Hz, 4J = 1.7 Hz, 1 H, H11b), 5.18 (td, 3J = 10.8 Hz, 2J = 1.7 Hz, 4J = 
1.7 Hz, 1 H, H11a), 5.36 (br d, 1 H, H9), 5.93 (ddd, 3J = 17.1 Hz, 3J = 10.6 Hz, 3J = 6.4 
Hz, 1 H, H10), 6.93 (tt, 3JH4’’,F  = 8.6 Hz, 4J = 2.3 Hz, 1 H, H4’’), 7.27–7.34 (m, 2 H, 
H2’’), 7.46 (d, 3J = 4.4 Hz, 1 H, H3’), 7.56–7.67 (m, 1 H, H6’), 7.68–7.79 (m, 1 H, 
H7’), 7.87 (br s, 1 H, NH), 8.15 (dd, 3J = 8.3 Hz, 4J = 1.2 Hz, 1 H, H8’), 8.39 (d, 3J = 7.9 
Hz, 1 H, H5’), 8.88 (d, 3J = 4.4 Hz, 1 H, H2’) 
 
MS (EI, 70eV): m/z (%) = 136.3 (100) [quinuclidine], 141.2 (62) [3,5-di-F-PhCO], 
433.1 (10) [M] 
 
Optical rotary power:  
D][α  = 243°, 578][α  = 270°, 546][α  = 311°, 436][α  = 588° (c = 0.54, CHCl3) 
   
Elemental analysis:   
calcd. for C26H25F2N3O · 2.2 H2O: C  69.22 H  6.57 N  9.31 
            found: C  68.94 H  6.09 N  9.16 
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5.4.2.8 N-(9-Deoxyepicinchonine-9-yl)-3,5-dimethoxybenzamide (37) 
 
 
29 (590 mg, 2.01 mmol), CH2Cl2 (12 mL), NEt3 (4.1 mL) and 3,5-dimethoxybenzoyl 
chloride118 (522 mg, 2.60 mmol), CH2Cl2 (3 mL). The hydrochloride was dissolved in 
MeOH, precipitated with acetone and stored at –30 °C. The free base was recrystallized 
from Et2O.  
 
C28H31N3O3 (457.6) 
Yield:          330 mg (0.72 mmol, 36%),  
                     Colorless solid 
Mp:           123–125 °C  
 
IR (KBr):   ν [cm-1] = 3340m (N–H); 3100w, 3020w, 2950m, 2880w, 2860w (C–H); 
1600s (amide I); 1535s (C=C); 1515m (amide II) 
 
1H NMR (300 MHz, CDCl3): δ [ppm] = 0.91–1.07 (m, 1 H, H7b) ,  1.46–1.73 (m, 4 H, 
H4, H5, H7a), 2.24–2.38 (m, 1 H, H3), 2.76–3.15 (m, 5 H, H2, H6, H8), 3.79 (s, 6 H, 
OCH3), 5.12 (td, 3J = 17.3 Hz, 2J = 1.5 Hz, 4J = 1.5 Hz, 1 H, H11b), 5.18 (td, 3J = 10.6 
Hz, 2J = 1.4 Hz, 4J = 1.4 Hz, 1 H, H11a), 5.93 (ddd, 3J = 17.2 Hz, 3J = 10.6 Hz, 3J = 6.4 
Hz, 1 H, H10), 6.57 (t, 4J = 1.8 Hz, 1 H, H4’’), 6.95 (d, 4J = 2.2 Hz, 2 H, H2’’), 7.48 (d, 
3J = 4.4 Hz, 1 H, H3’), 7.55–7.66 (m, 1 H, H6’), 7.67–7.77 (m, 1 H, H7’), 7.90 (br s, 1 
H, NH), 8.13 (dd, 3J = 8.4 Hz, 4J = 1.0 Hz, 1 H, H8’), 8.47 (d, 3J = 8.0 Hz, 1 H, H5’), 
8.87 (d, 3J = 4.7 Hz, 1 H, H2’) 
 
MS (EI, 70eV): m/z (%) = 165.2 (100) [3,5-di-MeO-PhCO], 276.3 (84) [M – 3,5-di-
MeO-PhCONH], 457.2 (45) [M] 
 
Optical rotary power:  
D][α  = 267°, 578][α  = 274°, 546][α  = 318°, 436][α  = 610° (c = 0.52, CHCl3) 
 
Elemental analysis:   
  calcd. for C28H31N3O3 · H2O:  C  70.71 H  6.99 N  8.84 
    found:  C  70.30 H  6.94 N  8.76 
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5.4.2.9 N-(9-Deoxyepicinchonine-9-yl)-3,5-dinitrobenzamide (38) 
 
 
As the acid chloride is almost insoluble in CH2Cl2, CHCl3 was used for this batch. 29 
(500 mg, 1.70 mmol), CHCl3 (9 mL), NEt3 (3.5 mL) and 3,5-dinitrobenzoyl chloride 
(575 mg, 2.49 mmol), CHCl3 (20 mL). The hydrochloride was dissolved in MeOH and 
precipitated with Et2O (–30 °C). 
 
C26H25N5O5 (487.5) 
Yield:          190 mg (0.39 mmol, 23%),  
                     yellow-brown solid 
Mp:            196–199 °C  
 
IR (KBr):   ν [cm-1] = 3320m (N–H); 3100m, 2940s, 2870m (C–H); 1660s, 1640s 
(amide I); 1590m (C=C); 1540s (amide II) 
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 0.77–0.97 (m, 1 H, H7b), 0.97–1.76 (m, 4 H, 
H4, H5, H7a), 2.27–2.42 (m, 1 H, H3), 2.73–3.28 (m, 5 H, H2, H6, H8), 5.14 (td, 3J = 
17.2 Hz, 2J = 1.5 Hz, 4J = 1.5 Hz, 1 H, H11b), 5.21 (td, 3J = 10.5 Hz, 2J = 1.4 Hz, 4J = 
1.4 Hz, 1 H, H11a), 5.46 (br s, 1 H, H9), 5.94 (ddd, 3J = 17.1 Hz, 3J = 10.5 Hz, 3J = 6.5 
Hz, 1 H, H10), 7.46 (d, 3J = 4.4 Hz, 1 H, H3’), 7.61–7.71 (m, 1 H, H6’), 7.71–7.81 (m, 
1 H, H7’), 8.14 (dd, 3J = 8.5 Hz, 4J = 1.2 Hz, 1 H, H8’), 8.38 (dd, 3J = 8.4 Hz, 4J  = 0.8 
Hz, 1 H, H5’), 8.87 (d, 3J = 4.4 Hz, 1 H, H2’), 8.93 (d, 4J = 2.1 Hz, 2 H, H2’’), 9.13 (t, 
4J = 2.1 Hz, 1 H, H4’’) 
 
MS (EI, 70eV): m/z (%) = 43.2 (37) [C2H5N], 136.3 (100) [quinuclidine], 487.1 (14) 
[M] 
 
Optical rotary power:  
D][α  = 236°, 578][α  = 248°, 546][α  = 286°, 436][α  = 541° (c = 0.51, CHCl3) 
 
Elemental analysis:  calcd.:  C  64.06 H  5.17 N  14.37 
    found:  C  63.74 H  5.60 N  14.40 
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5.4.2.10 N-(9-Deoxyepicinchonine-9-yl)-4-tert-butylbenzamide (39) 
 
 
29 (908 mg, 3.09 mmol), CH2Cl2 (16 mL), NEt3 (6.4 mL) and 4-tert-butylbenzoyl 
chloride (755 mg, 3.84 mmol), CH2Cl2 (4 mL). After dissolution in Et2O the product 
was precipitated with PE 40/60 and stored at –30 °C.  
 
C30H35N3O (453.6) 
Yield:         390 mg (0.86 mmol, 28%),  
                    colorless solid 
Mp:          122–124 °C  
 
IR (KBr):   ν [cm-1] = 3280m (N–H); 3100m, 2960s, 2880s (C–H); 1640s (amide I); 
1600m, 1555 (C=C); 1515 (amide II) 
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 0.90–1.10 (m, 1 H, H7b), 1.32 (s, 9 H, CH3), 
1.19–1.71 (m, 4 H, H4, H5, H7a), 2.23–2.38 (m, 1 H, H3), 2.76–3.17 (m, 5 H, H2, H6, 
H8), 5.12 (td, 3J = 17.2 Hz, 3J = 1.5 Hz, 4J = 1.5 Hz, 1 H, H11b), 5.17 (td, 3J = 10.6 Hz, 
3J = 1.5 Hz, 4J = 1.5 Hz, 1 H, H11a), 5.38 (br d, 1 H, H9), 5.93 (ddd, 3J = 17.1 Hz, 
3J = 10.6 Hz, 3J = 6.5 Hz, 1 H, H10), 7.45 (d , 3J = 8.7 Hz, 2 H, H3’’, H5’’), 7.49 (d, 3J 
= 4.6 Hz, 1 H, H3’),  7.55–7.65 (m, 1 H, H6’), 7.67–7.75 (m, 1 H, H7’), 7.75 (d, 3J = 
8.7 Hz, 2 H, H2’’, H6’’), 7.90 (s, 1 H, NH), 8.13 (dd, 3J = 8.4 Hz, 4J = 1.2 Hz, 1 H, 
H8’), 8.45 (dd, 3J = 8.5 Hz, 4J = 1.0 Hz, 1 H, H5’), 8.86 (d, 3J = 4.6 Hz, 1 H, H2’) 
 
MS (PI-EI, 70eV): m/z (%) = 161.3 (100) [4-tert-butyl-PhCO], 276.4 (88) [M – 4-tert-
butyl-PhCONH], 453.6 (38) [M] 
 
Optical rotary power:  
D][α  = 266°, 578][α  = 279°, 546][α  = 322°, 436][α  = 616° (c = 0.53, CHCl3) 
 
Elemental analysis:  
calcd. for C30H35N3O · 1.2 H2O: C  75.82 H  7.93 N  8.84 
         found: C  75.45 H  8.17 N  8.84 
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5.4.2.11 N-(9-Deoxyepicinchonine-9-yl)-adamantanecarboxamide (40) 
 
 
29 (1.07 g, 3.66 mmol), CH2Cl2 (18 mL), NEt3 (7 mL) and 1-adamantanecarboxylic acid 
chloride (884 mg, 4.45 mmol), CH2Cl2 (4 mL).  
  
C30H37N3O (455.6) 
Yield:         910 mg (2.00 mmol, 55%),  
                    colorless solid 
Mp:          81–82 °C  
 
IR (KBr):   ν [cm-1] = 3660m (N–H); 3080w, 2910s, 2860s (C–H); 1650s (amide I); 
1590m, 1570w; 1510s (amide II) 
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 0.79–1.05 (m, 1 H, H7b), 1.29–1.91 (m, 19 H, 
H4, H5, H7a, adamantane-H), 2.20–2.39 (m, 1 H, H3), 2.64–2.81 (m, 1 H, H2),  2.85–
3.08 (m, 4 H, H2, H6, H8), 5.09 (br s, 1 H, H9), 5.10 (td, 3J = 17.3 Hz, 2J = 1.5 Hz, 4J = 
1.5 Hz, 1 H, H11b), 5.16 (td, 3J = 10.6 Hz, 2J = 1.5 Hz, 4J = 1.5 Hz, 1 H, H11a), 5.92 
(ddd, 3J = 17.1 Hz, 3J = 10.4 Hz, 3J = 6.6 Hz, 1 H, H10), 7.37 (d, 3J = 4.8 Hz, 1 H, H3’), 
7.50–7.61 (m, 1 H, H6’), 7.64–7.74 (m, 1 H, H7’), 8.10 (dd, 3J = 8.5 Hz, 4J = 1.0 Hz, 1 
H, H8’), 8.35 (dd, 3J = 8.7 Hz, 4J = 0.8 Hz, 1 H,  H5’), 8.84 (d, 3J = 4.4 Hz, 1 H, H2’) 
 
MS (FD, CH2Cl2): m/z (%) = 455.5 (100) [M] 
 
Optical rotary power:  
D][α  = 192°, 578][α  = 194°, 546][α  = 223°, 436][α  = 414° (c = 0.51, CHCl3) 
 
Elemental analysis:   
calcd. for C30H37N3O · 1/3 H2O: C  78.06 H  8.22 N  9.10 
          found: C  78.27 H  8.45 N  8.45 
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5.4.3 Further cinchona alkaloid derivatives  
 
 
5.4.3.1 N-(9-Deoxyepicinchonine-9-yl)-4-methylbenzenesulfonamide (43) 
 
29 (960 mg, 3.27 mmol), toluene-4-sulfonyl chloride (938 mg, 4.92 mmol) and K2CO3 
(540 mg, 3.90  mmol) were stirred in CH2Cl2 (20 mL) at room temp. for 10 h. The 
reaction mixture was diluted with CH2Cl2, K2CO3 was removed by filtration and the 
solution was washed 3 × with saturated Na2CO3 solution. Chomatography on SiO2 with 
EtOAc:MeOH (9:1).  
 
C26H29N3O2S (447.6) 
Yield:  460 mg (1.03 mmol, 31%),  
             colorless solid 
Mp:   190–192 °C  
 
IR (KBr):  ν [cm-1] = 3440w (N–H), 3140w, 3090m, 3070m, 2940s, 2870m, 2880m 
(C–H); 1650w, 1600s, 1580m, 1520s, 1460s (C=C); 1390s, 1330s, 1170s (sulfonamide)  
 
1H NMR (250 MHz, CDCl3): δ [ppm] = δ = 0.71–0.93 (m, 1 H, H7b), 1.08–1.68 (m, 4 
H, H4, H5, H7a), 2.35 (s, 3 H, CH3), 2.13–2.42 (m, 1 H, H3), 2.62–2.97 (m, 3.7 H, H2, 
H6, H8), 3.17–3.31 (m, 0.3 H, H8), 4.20 (br d, 3J = 10.7 Hz, 0.3 H, H11b), 4.82–4.96 
(m, 1.7 H, H9, H11b), 5.12 (td, 3J = 10.6 Hz, 2J = 1.4 Hz, 4J = 1.4 Hz, 1 H, H11a), 5.76 
(ddd, 3J = 17.2 Hz, 3J = 10.6 Hz, 3J = 5.8 Hz, 1 H, H10), 6.83 (d, 3J = 8.1 Hz, 0.6 H, 
H3’’, H5’’), 7.07 (d, 3J = 8.0 Hz, 1.4 H, H3’’, H5’’), 7.17 (d, 3J = 4.3 Hz, 0.3 H, H3’), 
7.33 (d, 3J = 8.4 Hz, 0.6 H, H2’’, H6’’), 7.39–7.46 (m, 2.4 H, H2’’, H3’, H6’’, H7’), 
7.55–7.64 (m, 1 H, H6’), 7.68–7.77 (m, 0.7 H, H7’), 7.98 (d, 3J = 8.4 Hz, 0.3 H, H8’), 
8.04 (d, 3J = 8.5 Hz, 0.7 H, H8’), 8.10 (dd, 3J = 8.5 Hz, 4J = 0.9 Hz, 0.7 H, H5’), 8.41 (d, 
3J = 8.4 Hz, 0.3 H, H5’), 8.71 (d, 3J = 4.6 Hz, 0.7 H, H2’), 8.74 (d, 3J = 4.2 Hz, 0.3 H, 
H2’)  
 
1H NMR (400 MHz, C2D2Cl4, 110 °C): δ [ppm] = 0.77–0.92 (m, 1 H, H7b), 1.12–1.23 
(m, 1 H, H7a), 1.37–1.64 (m, 3 H, H4, H5), 2.15–2.31 (m, 1 H, H3), 2.24 (s, 3 H, CH3), 
2.43–2.57 (m, 1 H, H2), 2.76–3.12 (m, 4 H, H2, H6, H8), 4.75 (br s, 1 H, H9), 4.95 (td, 
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3J = 17.4 Hz, 2J = 1.5 Hz, 4J = 1.5 Hz, 1 H, H11b), 5.12 (td, 3J = 10.6 Hz, 2J = 1.4 Hz, 4J 
= 1.4 Hz, 1 H, H11a), 5.76 (ddd, 3J = 17.3 Hz, 3J = 10.7 Hz, 3J = 5.9 Hz, 1 H, H10), 
6.92 (d, 3J = 7.9 Hz, 2 H, H3’’, H5’’), 7.21–7.38 (m, 1 H, H3’), 7.33 (d, 3J = 8.3 Hz, 2 
H, H2’’, H6’’), 7.43–7.54 (m, 1 H, H6’),  7.57–7.68 (m, 1 H, H7’), 8.03 (d, 3J = 8.4 Hz, 
4J = 0.3 Hz, 1 H, H8’), 8.06–8.20 (m, 1 H, H5’), 8.68 (d, 3J = 4.5 Hz, 1 H, H2’)  
 
MS (EI, 70eV): m/z (%) = 136.3 (100) [quinuclidine]; 292.3 (86) [M – 4-Me-PhSO2], 
447.1 (17) [M] 
 
Optical rotary power:  
D][α  = 52°, 578][α  = 55°, 546][α  = 62°, 436][α  = 108°  (c = 0.51, CHCl3) 
 
Elemental analysis:  calcd.:  C  69.77 H  6.53 N  9.39 
    found:  C  69.20 H  6.92 N  9.32 
 
 
 
5.4.3.2 N-(9-Deoxyepicinchonine-9-yl)-3,5-di-tert-butylbenzenesulfonamide (44) 
 
 
5.4.3.2.1 3,5-Di-tert-butylbenzenesulfonyl chloride (40)69 
 
To 1,3,5-tri-tert-butylbenzene (5.00 g, 20.3 mmol) chlorosulfonic acid (13.3 mL, 65.4 
mmol) was added dropwise at 0 °C. The resulting dark solution was stirred for 1 h at 
room temp. Then it was poured into ice-water, the resulting precipitate was washed and 
chromatographed on SiO2 (EtOAc/hexane 1:24). 
 
C14H21ClSO2 (288.8) 
Yield:  3.17 g (11.0 mmol, 54.2%),  
             colorless solid 
bp:   90–92 °C (lit. 81–83 °C) 
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 1.52 (s, 18 H, CH3), 7.71 (d, 4J = 2.1 Hz, 2 H, 
H2), 7.90 (s, 1H, H4) 
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5.4.3.2.2 N-(9-Deoxyepicinchonine-9-yl)-3,5-di-tert-butylbenzenesulfonamide (44) 
 
 
29 (650 mg, 2.22 mmol), 3,5-di-tert-butylbenzenesulfonyl chloride (962 mg, 3.33 
mmol) and K2CO3 (360 mg, 2.60 mmol) in CH2Cl2 (20 mL) were stirred at room temp. 
for 10 h. The reaction mixture was diluted with CH2Cl2 and K2CO3 was filtered off. The 
organic layer was washed 3 × with saturated Na2CO3 solution. The crude product was 
chromatographed on SiO2 with MeOH.  
 
C33H43N3O2S (545.8) 
Yield:  340 g (0.62 mmol, 28%),  
             colorless solid 
Mp:   95–98 °C  
 
IR (KBr):  ν [cm-1] = 3420w (N–H); 3200w, 3080w, 2960s, 2870m (C–H); 1640w, 
1600m, 1575w, 1515m, 1480m, 1460m (C=C); 1370s, 1335s, 1170s (sulfonamide) 
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 0.65–0.88 (m, 1.7 H, H7a, H7b), 0.94–1.01 (m, 
0.3 H, H7a), 1.04–1.66 (m, 3 H, H4, H5), 1.3 (s, 18 H, CH3), 2.11–2.34 (m, 1 H, H3), 
2.58–2.78 (m, 4.7 H, H2, H6, H8), 3.13–3.34 (m, 0.3 H, H8), 4.12 (d, 3J = 10.7 Hz, 1 H, 
H11b), 4.75–4.92 (m, 2 H, H9, H11b), 5.00–5.11 (m, 1 H, H11a), 5.71 (ddd, 3J = 17.3 
Hz, 3J = 10.7 Hz, 3J = 5.4 Hz, 1 H, H10), 7.11 (d, 3J = 4.3 Hz, 0.3 H, H3’), 7.36–7.40 
(m, 0.3 H, H4’’), 7.41–7.53 (m, 3.4 H, H2’’, H3’, H3’’, H4’’), 7.53–7.63 (m, 1 H, H6’), 
7.66–7.76 (m, 1 H, H7’), 8.01 (d, 3J = 8.5 Hz, 0.3 H, H8’), 8.06 (d, 3J = 8.1 Hz, 0.7 H, 
H8’),  8.08 (dd, 3J = 8.4 Hz, 4J = 0.8 Hz, 0.7 H, H5’), 8.53 (d, 3J = 8.3 Hz, 0.3 H, H5’), 
8.72 (d, 3J = 4.6 Hz, 0.7 H, H2’), 8.74 (d, 3J = 4.5 Hz, 0.3 H, H2’) 
 
MS (FD, CH2Cl2): m/z (%) = 545.6 (100) [M]; 1090.9 (2) [2M] 
 
Optical rotary power:  
D][α  = 57°, 578][α  = 60°, 546][α  = 67°, 436][α  = 125° (c = 0.55, CHCl3) 
 
Elemental analysis:  calcd.:  C  72.62 H  7.94 N  7.70 
    found:  C  72.20 H  8.00 N  7.44 
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5.4.3.3 N-(9-Deoxyepicinchonine-9-yl)-2,4-dinitrophenylamine (45) 
 
 
29 (510 mg, 1.74 mmol) and 2,4-dinitrofluorobenzene (324 mg, 1.74 mmol) were 
stirred in CH2Cl2 (15 mL) at room temp. for 10 h. A yellow powder precipitated. The 
solvent was removed in vacuo and the residue was recrystallized from Et2O.  
 
C25H25N5O4 (459.5) 
Yield:          400 mg (0.87 mmol, 50%),  
                     intensely yellow powder  
Mp:           200–202 °C  
 
IR (KBr):  ν [cm-1] = 3440w, 3280w (N–H); 3120w, 3090w, 2950s, 2890m (C–H); 
1620s, 1590s, 1505s (C=C); 1455w, 1420w (C–H) 
 
1H NMR (300 MHz, CDCl3): δ [ppm] = 0.87–1.08 (m, 1 H, H7b), 1.34–1.79 (m, 4 H, 
H4, H5, H7a), 2.28–2.45 (m, 1 H, H3), 2.65–2.84 (m, 1 H, H2), 2.95–3.22 (m, 4 H, H2, 
H6, H8), 5.13 (td, 3J = 17.3 Hz, 2J = 1.5 Hz, 4J = 1.5 Hz, 1 H, H11b), 5.21 (br td, 1 H, H 
11a), 5.94 (ddd, 1H, 3J = 17.2 Hz, 3J = 8.8 Hz, 3J = 6.3 Hz, 1 H, H10), 6.26 (br s, 1H, 
H9), 7.51 (d, 3J = 4.5 Hz, 1 H, H3’), 7.65–7.93 (m, 3 H, H6’’, H6’, H7’), 7.85 (d, 3J = 
8.8 Hz, 1 H, H5’’), 8.23 (d, 3J = 7.8 Hz, 1 H, H8’), 8.33 (dd, 3J = 8.6 Hz, 4J = 0.6, 1 H, 
H5’), 8.90 (d, 3J = 4.4 Hz, 1 H, H2’), 9.09 (d, 4J = 2.7 Hz, 1 H, H3’’), 9.84 (br s, 1 H, 
NH) 
 
MS (EI, 70 eV): m/z (%) = 136.1 (100) [quinuclidine], 413.1 (19) [M – NO2], 459.1 
(30) [M] 
 
Optical rotary power:  
D][α  = 652°, 578][α  = 687°, 546][α  = 847° (c = 0.51, CHCl3) 
 
Elemental analysis:  calcd.:  C  65.35 H  5.48 N  15.24 
    found:  C  65.02 H  5.49 N  14.99 
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5.4.3.4 N-(9-Deoxyepicinchonine-9-yl)-N’-phenylurea (46) 
 
 
29 (276 mg, 0.94 mmol) was heated to 60 °C with phenylisocyanate (10 mL, 91.5 
mmol) for 10 min. After further 15 min at room temp. the precipitate was collected, 
washed with PE 40/60 and recrystallized from Et2O.  
 
C26H28N4O (412.5) 
Yield:        180 mg (0.44 mmol, 46%),  
                   colorless solid 
Mp:         217–218 °C  
 
IR (KBr): ν [cm-1] = 3280m (N–H); 3190w, 3120w, 3070w, 2910m, 2060w (C–H); 
1690s (amide I); 1550s, 1510m (amide II); 1495s, 1440m (C=C)  
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 0.80–0.97 (m, 1 H, H7b), 1.15–1.68 (m, 4 H, 
H4, H5, H7a), 2.19–2.36 (m, 1 H, H3), 2.77–3.06 (m, 5 H, H2, H6, H8), 5.10 (td, 3J = 
14.7 Hz, 2J = 1.5 Hz, 4J = 1.5 Hz, 1 H, H11b), 5.15 (td, 3J = 14.7 Hz, 2J = 1.5 Hz, 4J = 
1.5 Hz, 1 H, H11a), 5.30 (br d, 1 H, H9), 5.89 (ddd, 3J = 17.1 Hz, 3J = 10.5 Hz, 3J = 6.6 
Hz, 1 H, H10), 6.28 (br s, 1 H, RNH), 6.90–7.04 (m, 1 H, PhNH), 7.13–7.32 (m, 5 H, 
Ph), 7.47 (d, 3J = 4.6 Hz, 1 H, H3’), 7.54–7.66 (m, 1 H, H6’), 7.67–7.77 (m, 1 H, H7’), 
8.14 (dd, 3J = 8.4 Hz, 4J = 1.1 Hz, 1 H, H8’), 8.40 (dd, 3J = 8.6 Hz, 4J = 0.9 Hz, 1 H, 
H5’), 8.88 (d, 3J = 4.6 Hz, 1 H, H2’) 
 
MS (EI, 70 eV): m/z (%) = 136.1 (100) [quinuclidine], 119.1 (72) [PhNCO], 412.0 (5) 
[M] 
 
Optical rotary power:  
D][α  = 193°, 578][α  = 202°, 546][α  = 232°, 436][α  = 429° (c = 0.29, CHCl3) 
 
Elemental analysis:  calcd.:  C  75.70 H  6.84 N  13.58 
    found:  C  75.52 H  6.86 N  13.48 
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5.4.3.5 Cinchonine-9-yl phenylcarbamate (47)71 
 
Cinchonine (1.50 g, 5.10 mmol) was heated to 80 °C in phenylisocyanate (10 mL, 91.5 
mmol) for 10 h. The excess of phenylisoyanate was removed in vacuo. The residue was 
stirred in boiling Et2O, cooled to –30 °C and collected.  
 
C26H27N3O2 (413.5) 
Yield:          530 mg (1.25 mmol, 25%),  
                     colorless solid 
Mp:           190–191 °C (Lit. 198 °C) 
 
IR (KBr):    ν [cm-1] = 3440w (N–H); 3240w, 3200w, 3200w, 3130w, 2960s, 2880m 
(C–H); 1730s (amide I); 1620m, 1605m (C=C);  1560s (amide II); 1520m, 1500m (C–
H) 
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 1.16–1.31 (m, 1H, H7b), 1.41–1.97 (m, 4 H, 
H4, H5, H7a), 2.20–2.34 (m, 1 H, H3), 2.61–2.90 (m, 2 H, H2, H6), 3.24–3.41 (m, 1 H, 
H8), 5.08 (td, 3J = 9.7 Hz, 2J = 1.5 Hz, 4J = 1.5 Hz, 1 H, H11b), 5.12 (td, 3J = 8.9 Hz, 2J 
= 1.4 Hz, 4J = 1.4 Hz, 1 H, H11a), 6.03 (ddd, 3J = 17.1 Hz, 3J = 10.5 Hz, 3J = 7.2 Hz, 1 
H, H10), 6.57 (d, 3J = 8.0 Hz, 1 H, Ph-H), 6.82 (br s, 1 H, H9), 7.05 (t, 3J = 7.2 Hz, 1 H, 
Ph-H), 7.19–7.39 (m, 3 H, Ph-H), 7.44 (d, 3J = 4.5 Hz, 1 H, H3’), 7.54–7.64 (m, 1 H, 
H6’), 7.66–7.78 (m, 1 H, H7’), 8.13 (dd, 3J = 8.4 Hz, 4J = 0.7 Hz, 1 H, H8’), 8.25 (d, 3J 
= 8.5 Hz, 4J = 0.9 Hz, 1 H, H5’), 8.89 (d, 3J = 4.5 Hz, 1 H, H2’) 
 
MS (EI, 70 eV): m/z (%) = 119.0 (46) [PhNCO], 136.1 (100) [quinuclidine], 413.1 (33) 
[M] 
 
Optical rotary power:  
D][α  = 53°, 578][α  = 56°, 546][α  = 61°, 436][α  = 102° (c = 0.54, CHCl3) 
 
Elemental analysis:  calcd.:  C  75.52 H  6.58 N  10.16 
    found:  C  75.00 H  6.49 N  10.27 
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5.4.3.6 Cinchonine-9-yl 3,5-di-tert-butylbenzenesulfonate (48) 
 
 
Cinchonine (424 mg, 1.44 mmol) and NaH (40.8 mg, 1.70 mmol) were refluxed in THF 
(10 mL) for 2 h. The mixture was cooled to 0 °C,  3,5-di-tert-butylbenzenesulfonyl 
chloride (500 mg, 1.73 mmol) in THF (10 mL) was added dropwise. After refluxing for 
10 h, the solvent was removed. The residue was taken up in 2 M HCl and the aqueous 
phase was washed 3 × with Et2O. After making basic with 2 M NaOH, the aqueous 
phase was extracted 3 × with Et2O. The combined organic layers were dried over 
Na2SO4 and evaporated. The slightly brown powder was washed with MeOH and 
recrystallized from Et2O.  
 
C33H42N2O3S (546.8) 
Yield:  300 mg (0.55 mmol, 39%),  
             colorless solid  
Mp:   180–182 °C  
 
IR (KBr):  ν [cm-1] = 3070w, 2970s, 2940s, 2880s (C–H); 1600m, 1510m, 1480m, 
1470m, 1455m (C=C); 1370s, 1360s (S=O); 1320m, 1250m; 1190s (S=O)  
 
1H NMR (300 MHz, CDCl3): δ [ppm] = 1.07 (s, 18 H, CH3), 1.79–2.01 (m, 5 H, H4, 
H5, H7a, H7b), 2.19–2.33 (m, 1 H, H3), 2.54–3.40 (m, 5 H, H2, H6, H8), 5.06–5.17 (m, 
2 H, H11a, H11b), 5.98 (ddd, 3J = 16.5 Hz, 3J = 10.8 Hz, 3J = 7.6 Hz, 1 H, H10), 7.14 
(m, 1H, H3’), 7.32 (t, 4J = 1.8 Hz, 1 H, H4’’), 7.35–7.42 (m, 2 H, H2’’), 7.50–7.58 (m, 
1 H, H6’), 7.61–7.69 (m, 1 H, H7’), 7.99 (dd, 3J = 8.5 Hz, 4J = 0.9 Hz, 1 H, H5’), 8.61 
(d, 3J = 4.5 Hz, 1 H, H2’) 
 
MS (DCI, NH3): m/z (%) = 279.6 (100) [M – di-tert-butyl-PhSO2], 547.4 (12) [MH] 
 
Optical rotary power:  
D][α  = 40°, 578][α  = 40°, 546][α  = 45°, 436][α  = 71° (c = 0.54, CHCl3) 
 
Elemental analysis:  calcd.:  C  72.49 H  7.74 N  5.12 
    found:  C  72.25 H  7.59 N  5.17 
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5.4.3.7 (3R,8R,9S)-10,11-Dihydro-3,9-epoxy-6’-hydroxycinchonane (50)72 
 
Quinidine (5.00 g, 15.4 mmol) and KBr (18.4 g, 159 mmol) were refluxed in H3PO4 
(85%, 75 mL) for 7 d at 100 °C. The cool reaction mixture was dropped in KOH (25%, 
500 mL) and adjusted to pH = 8 with aqueous NH3. After 3 × extraction with CHCl3, 
the residue was chromatographed on SiO2 (MeOH:CHCl3 1:9 → 1:4). Recrystallisation 
from MeOH:H2O (1:1).  
 
C19H22N2O2 (310.4) 
Yield:          1.55 g (4.99 mmol, 32%),  
                     colorless solid 
Mp:           238–240 °C (lit. 258–259 °C) 
 
IR (KBr):    ν [cm-1] = 3500–2200br (OH); 2960m, 2880m (C–H); 1640s, 1600m 
(C=C); 1510s, 1480s, 1490m, 1420m (C–H) 
 
1H NMR (250 MHz, CDCl3): δ [ppm] = 1.05 (t, 3J = 7.8 Hz, 3 H, H11), 1.22 (dd, 3J = 
12.5 Hz, 3J = 6.9 Hz, 1 H, H7b), 1.53–1.81 (m, 2 H, H5), 1.69 (q, 3J = 7.8 Hz, 2 H, 
H10), 1.87 (ddd, 3J = 12.9 Hz, 3J = 6.9 Hz, 4J = 1.8 Hz, 1 H, H7a), 2.12–2.31 (m, 1 H, 
H4), 2.79 (d, 2J = 13.6 Hz, 1 H, H2), 2.98–3.15 (m, 1 H, H6), 3.23 (dd, 3J = 12.7 Hz, 3J 
= 7.9 Hz, 1 H, H6), 3.45 (d, 3J = 6.2 Hz, 1 H, H8), 3.73 (d, 2J = 13.4 Hz, 1 H, H2), 6.05 
(s, 1H, H9), 7.25 (dd, 3J = 9.1 Hz, 4J = 2.5 Hz, 1 H, H5’), 7.65 (dd, 3J = 4.4 Hz, 4J = 0.9 
Hz, 1 H, H7’), 7.97 (d, 3J = 9.0 Hz, 1 H, H3’), 8.05 (dd, 3J = 2.5 Hz, 4J = 0.9 Hz, 1 H, 
H8’), 8.72 (d, 3J = 4.6 Hz, 1 H, H2’) 
 
MS (PI–EI, 70eV): m/z = 253 (100) [M – C4H9], 310.1 (36) [M] 
 
Optical rotary power:  
 D][α  = –15°, 578][α  = –15°, 546][α  = –12°, 436][α  = 42° (c = 1.03, EtOH) 
 
Elemental analysis:  calcd.:  C  73.52 H  7.14 N  9.03 
    found:  C  72.74 H  7.16 N  8.85 
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5.5 Catalysis 
 
 
5.5.1 The amino acid systems  
 
5.5.1.1 General standard procedure 
 
The substrates 1–3 (0.74 mmol) were stirred with 10 mol% optically active base in abs. 
THF (9 mL) under nitrogen for 24 h at 70 °C. Conversion was monitored with TLC 
(SiO2 plates) using EtOAc as eluent. Compounds 1–6 were made visible heating with 
molybdatophosphoric acid. 
The solvent was removed at room temp. and the residue was dissolved in EtOAc (25 
mL). 2 M HCl (15 mL) was added in order to remove the base as the hydrochloride. 
After extraction with EtOAc (3×25 mL), the organic layer was dried over Na2SO4 and 
evaporated at room temp. 
 
 
5.5.1.2 Characterisation of the products  
 
5.5.1.2.1 Ethyl N-acetylalaninate (4) 
 
C7H13NO3 (159.2) 
Properties: colorless oil 
 
IR (neat):  ν [cm-1] = 3280s (br) (N–H); 3060s, 2960s, 2920s (C–H); 1730s (C=O); 
1650s (amide I); 1530s (amide II); 1440s, 1360s (C-H)  
 
1H NMR (250 MHz, [D6]DMSO): δ [ppm] = 1.16 (t, 3J = 7.1 Hz, 3 H, CH2CH3), 1.23 
(d, 3J = 7.2 Hz, 3 H, CH3), 1.82 (s, 3 H, COCH3), 4.06 (q, 3J = 7.1 Hz, 2 H, CH2CH3), 
4.19 (dq, 3J = 7.2 Hz, 3J = 7.2 Hz, 1 H, CH), 8.24 (br d, 3J = 7.2 Hz, 1 H, NH) 
 
1H NMR conversion control: COCH3 signal of 1/4 δ = 1.86/1.82 ppm 
 
GC conditions: Column Restek Rt-ß DEX cst (30 m length, 0.32 mm i.d.), injector 
temp. 260 °C, detector temp. 260 °C (flame ionisation), column temp. 115 °C, H2 
pressure 0.7 bar, retention times for enantiomers D/L 10.9/11.7 min.  
20][ Dα  = – 65.6° (c = 0.55, H2O)119 for ethyl N-acetyl-L-alaninate 
H
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5.5.1.2.2 Ethyl N-acetylvalinate (5) 
 
C9H17NO3 (187.2) 
Properties: colorless oil 
 
IR (neat): ν [cm-1] = 3300s (N–H); 3070w, 2960m, 2990w, 2880w (C–H); 1740s 
(C=O); 1660s (amide I); 1550s (amide II); 1470m, 1380s (C-H)  
 
1H NMR (250 MHz, [D6]DMSO): δ [ppm] = 0.86, 0.87 (2 d, 3J = 6.7 Hz, 6 H, 
CH(CH3)2), 1.17 (t, 3J = 7.1 Hz, 3 H, CH2CH3), 1.86 (s, 3 H, COCH3), 1.99 (oct, 3J = 
6.7 Hz, 1 H, CH(CH3)2), 3.96–4.22 (m, 3 H, CH2CH3, CH), 8.09 (d, 3J = 7.9 Hz, 1 H, 
NH) 
 
1H NMR conversion control: COCH3 signal of 2/5 δ = 1.89/1.86 ppm 
 
GC conditions: Column Macherey-Nagel Lipodex-E (50 m length, 0.25 mm i.d.), 
injector temp. 260 °C, detector temp. 260 °C (flame ionisation), column temp. 125 °C, 
He pressure 2 bar, retention times for enantiomers D/L 25.2/27.0 min.  
 
31][ Dα  = – 30.8° (c = 1.00, EtOH)120 for ethyl N-acetyl-L-valinate 
 
 
5.5.1.2.3 Ethyl N-acetylphenylalaninate (6) 
 
C13H17NO3 (235.4) 
Properties: colorless solid 
Mp:          63–65 °C (lit.121 68–69 °C) 
 
IR (neat):  ν [cm-1] = 3320s (N–H); 3030w, 2980w, 2940w (C–H); 1740s (C=O); 1650s 
(amide I); 1540s (amide II); 1450m, 1380m, 1360m (C–H)  
 
1H NMR (250 MHz, [D6]DMSO): δ [ppm] = 1.08 (t, 3J = 7.1 Hz, 3 H, CH2CH3), 1.78 
(s, 3 H, COCH3), 2.86, 2.97 (2 dd, 2J = 13.6 Hz, 3J = 8.9 Hz / 2J = 13.6 Hz, 3J = 6.1 Hz, 
2 H, benzyl H), 4.02 (q, 3J = 7.1 Hz, 2 H, CH2CH3), 4.40 (ddd, 3J = 7.7 Hz, 3J = 8.8 Hz, 
3J = 6.1 Hz, 1 H, CH), 7.15–7.32 (m, 5 H, Ph), 8.32 (d, 3J = 7.9 Hz, 1 H, NH), 
H
NH
OEtO
O
H
NH
OEtO
O
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1H NMR conversion control: COCH3 signal of 3/6 δ = 1.92/1.78 ppm 
 
GC conditions: Column Restek Rt-ß DEX cst (30 m length, 0.32 mm i.d.), injector 
temp. 260 °C, detector temp. 260 °C (flame ionisation), column temp. 155 °C, He 
pressure 1.2 bar, retention times for enantiomers D/L 12.0/13.6 min.  
 
23][ Dα  = 87.4° (c = 1.00, CHCl3)81 for ethyl N-acetyl-L-phenylalaninate 
 
 
5.5.2 The 2-fluoro-1-tetralone (12) system  
 
Benzyl-2-fluoro-1-tetralone-2-carboxylate 11 (50.4 mg, 0.17 mmol) and the chiral base 
(30 mol%, 0.051 mmol) were dissolved in acetonitrile (10 mL). Then the Pd catalyst 
(2.5 mol%, 4.25 µmol) was added and the hydrogen atmosphere was provided with 
gasbags. 
After the time given, the reaction mixture was filtered through 10 cm of Celite 545 
(washed with CH2Cl2) in order to remove the Pd on charcoal. The solvents were 
evaporated at room temp. In order to remove the base, the residue was filtered through a 
small SiO2 column with CH2Cl2.  
 
C10H9FO (164.2) 
Properties: slightly yellow oil 
 
IR (neat):  ν [cm-1] = 3130w, 2990w, 2900w (C–H); 1730s (C=O); 1630m (C=C); 
1510w, 1490w, 1460w (C–H)  
 
1H NMR (300 MHz, CDCl3): δ [ppm] = 2.20–2.38 (m, 1 H, CH2), 2.53 (dddd, 3J = 16.8 
Hz, 3J = 10.0 Hz, J = 35.3 Hz, 4J = 4.3 Hz, 1 H, CH2), 3.08 (dd, 3J = 9.6 Hz, 3J = 4.1 Hz, 
2 H, CH2), 5.10 (ddd, 2JH,F  = 47.9 Hz, 3J = 12.8 Hz, 3J = 5.2 Hz, 1 H, FCH), 7.22 (d, 3J 
= 7.7 Hz, 1 H, Ph), 7.30 (t, 3J = 7.5 Hz, 1 H, Ph), 7.48 (td, 3J = 7.5 Hz, 4J = 1.4 Hz, 1 H, 
Ph), 8.01 (dd, 3J = 8.0 Hz, 4J = 1.1 Hz, 1 H, Ph)  
 
19F NMR (250 MHz, CDCl3): δ [ppm] = –(191.36–190.25) (m)  
 
O
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HPLC conditions: Column Chiralcel OD-H, solvent hexane:isopropanol 97:3, flow 0.6 
mL/min, T = 25 °C, λ = 210 nm.  
Compounds detected: Tracer 2-methoxynaphthalene 12.4 min; 1-tetralone 13.4 min; 
(R)-(+)-2-fluoro-tetralone 22.2 min, (S)-(–)-2-fluoro-1-tetralone: 23.5 min; 2-fluoro-1-
tetralol: 25.8 min, 28.4 min (cis-isomers), 27.6 min, 30.0 min (trans-isomers); benzyl 2-
fluoro-1-tetralone-2-carboxylate 35.8 and 42.9 min. 
 
25][ Dα  = 64.9° (c = 0.43, dioxane)114 for (R)-(+)-2-fluoro-1-tetralone (ee > 95 %) 
 
 
Summary 
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6 Summary 
 
The enantioselective decarboxylation methodology was applied in order to obtain 
enantiomerically enriched α-amino acid derivatives. 2-N-Acetylamino-2-alkylmalonic 
acid monoethylesters 1–3 were suitable substrates for this purpose. Various cinchona 
alkaloid derivatives, mainly benzamide derivatives of 9-amino(9-deoxy)epicinchonine, 
were screened as catalysts. Full conversion was achieved stirring racemic hemiesters 1–
3 in THF at 70 °C with 10 mol% of a chiral base for 24 h (Figure 51). The chiral base 
may be recycled.  
 
 
 
 
 
 
 
Figure 51: Selected results of the decarboxylation of hemiesters 1–3  
 
While the commercially available cinchona alkaloids cinchonine, cinchonidine, quinine 
and quinidine gave poor results in first testings, benzamides of 9-amino(9-
deoxy)epicinchonine turned out to be effective catalysts. Independent of the alkyl 
substituent R of hemiesters 1–3, it was found that with ortho-substituted benzamide 32 
and also other ortho-substituted benzamides enantiomeric excess decreased 
dramatically. The phenylalanine system 3→6 delivered the best results with up to 70% 
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ee using N-(9-deoxyepicinchonine-9yl)-4-methoxybenzamide 34. Slightly inferior 
results were achieved in the alanine system 1→4 obtaining up to 60% ee with base 35. 
The valine system 2→5 gave generally worse results, except for catalyst 35. Besides 
benzamides of 9-amino(9-deoxy)epicinchonine, the corresponding sulfonamides 
showed similar results while other derivatives resulted in minor enantiomeric excess. 
 
A kinetic study with the alanine system 1→4 helped to confirm that no kinetic 
resolution occured in this catalytic reaction, as the enantiomeric excess stayed widely 
constant.  
 
Another approach in catalytic enantioselective decarboxylation is to start from ß-keto-
benzylesters, which are cleaved in the first step by Pd-induced hydrogenolysis. This 
cascade reaction was investigated starting from benzyl 2-fluoro-1-tetralone-2-
carboxylate 11 (Figure 52). 
 
 
 
 
 
Figure 52: The 2-fluoro-1-tetralone system 
 
The type of Pd on charcoal used was crucial. Pd/C type 807104 from Merck delivered 
reproducible results. Besides the desired product 2-fluoro-1-tetralone 12, two 
byproducts appeared, the defluorinated product 1-tetralone 23 and 2-fluoro-1-tetralol 
27.  
 
ß-Aminoalcohols proved to be inappropriate catalysts in this system, as they highly 
promoted defluoriniation and gave no enantiomeric excess. In contrast to the catalytic 
decarboxylation leading to α-amino acid derivatives, in the 2-fluoro-1-tetralone 12 
system the commercial cinchona alkaloids turned out to be successful catalytically 
active bases inducing up to 65% ee, while derivatives of them led to clearly decreased 
optical induction. 
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7 Zusammenfassung 
 
Die Methode der enantioselektiven Decarboxylierung wurde angewendet, um 
Enantiomeren-angereicherte α-Aminosäurederivate zu erhalten. 2-N-Acetylamino-2-
alkylmalonsäure monoethylester 1–3 waren geeignete Substrate hierfür. Verschiedene 
China-Alkaloidderivate, vor allem Benzamidderivate von 9-Amino(9-
deoxy)epicinchonin, wurden als Katalysatoren getestet. Voller Umsatz wurde erreicht 
durch Rühren der racemischen Hemiester 1–3 in THF bei 70 °C mit 10 mol% chiraler 
Base für 24 h (Abbildung 53). Die chirale Base kann zurückgewonnen werden.  
 
 
 
 
 
 
 
Abbildung 53: Ausgewählte Ergebnisse der Decarboxylierung von Hemiestern 1–3  
 
Während die kommerziellen China-Alkaloide Cinchonin, Cinchonidin, Chinin und 
Chinidin in ersten Tests schlechte Ergebnisse lieferten, erwiesen sich Benzamide von  
9-Amino(9-deoxy)epicinchonin als effektive Katalysatoren. Unabhängig vom 
Alkylsubstituenten R der Hemiester 1–3 zeigte sich, dass das ortho-substituierte 
Benzamid 32 und auch andere ortho-substituierte Benzamide den 
Enantiomerenüberschuss drastisch verringern. Das Phenylalanin-System 3→6 ergab die 
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besten Ergebnisse von bis zu 70% ee mit N-(9-Deoxyepicinchonin-9yl)-                       
4-methoxybenzamid 34. Geringfügig schlechtere Ergebnisse wurden mit dem         
Alanin-System 1→4 erreicht. Bis zu 60% ee wurden mit Base 35 erzielt.                     
Das Valin-System 2→5 zeigte generell schlechtere Ergebnisse, außer mit Katalysator 
35. Neben den Benzamiden von Amino(9-deoxy)epicinchonin erzielten die 
Sulfonamide ähnlich gute Ergebnisse, während andere Derivate zu geringeren 
Enantiomerenüberschüssen führten. 
 
Eine Reaktionskinetik mit dem Alanin-System 1→4 half zu bestätigen, dass in dieser 
Katalyse keine kinetische Racematspaltung auftritt, da der Enantiomerenüberschuss 
während der Reaktion weitgehend konstant blieb.  
 
Eine andere Methode der katalytischen enantioselektiven Decarboxylierung geht aus 
von ß-Keto-benzylestern, die in einem ersten Schritt durch Pd-induzierte 
Hydrogenolyse gespalten werden. Diese Kaskadenreaktion wurde untersucht für Benzyl 
2-fluor-1-tetralon-2-carboxylat 11 (Abbildung 54). 
 
 
 
 
 
Abbildung 54: Das 2-Fluor-1-tetralon-System 
 
Die Art des Palladiums auf Aktivkohle ist äußerst wichtig. Pd/C Typ 807104 von Merck 
lieferte reproduzierbare Ergebnisse. Außer dem gewünschten Produkt 2-Fluor-1-tetralon 
12 entstanden zwei Nebenprodukte, das defluorierte Produkt 1-Tetralon 23 und 2-Fluor-
1-tetralol 27.  
 
ß-Aminoalkohole erwiesen sich als ungeeignete Katalysatoren in diesem System, da sie 
die Defluorierung stark begünstigen und keinen Enantiomerenüberschuss erzielen. Im 
Gegensatz zur katalytischen Decarboxylierung, die zu α-Aminosäuren führt, waren im 
2-Fluor-1-tetralon-System 11→12 die kommerziellen China-Alkaloide erfolgreiche 
katalytisch aktive Basen mit einer optischen Induktion von bis zu 65% ee, während 
Derivate deutlich verringerte Enantiomerenüberschüsse lieferten.                                                     
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